CA2580621A1 - Nouveaux antibiotiques bicycliques - Google Patents
Nouveaux antibiotiques bicycliques Download PDFInfo
- Publication number
- CA2580621A1 CA2580621A1 CA002580621A CA2580621A CA2580621A1 CA 2580621 A1 CA2580621 A1 CA 2580621A1 CA 002580621 A CA002580621 A CA 002580621A CA 2580621 A CA2580621 A CA 2580621A CA 2580621 A1 CA2580621 A1 CA 2580621A1
- Authority
- CA
- Canada
- Prior art keywords
- methoxy
- pyran
- alpha
- tetrahydro
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940088710 antibiotic agent Drugs 0.000 title abstract description 8
- 239000003242 anti bacterial agent Substances 0.000 title abstract description 7
- 125000002619 bicyclic group Chemical group 0.000 title description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 77
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 32
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 29
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract description 25
- 150000002367 halogens Chemical group 0.000 claims abstract description 22
- 125000003118 aryl group Chemical group 0.000 claims abstract description 20
- 229910052720 vanadium Inorganic materials 0.000 claims abstract description 20
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 18
- 125000004438 haloalkoxy group Chemical group 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims description 450
- -1 OCH2 Chemical group 0.000 claims description 239
- 239000000203 mixture Substances 0.000 claims description 194
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 118
- 229910052739 hydrogen Inorganic materials 0.000 claims description 67
- 239000001257 hydrogen Substances 0.000 claims description 66
- 239000002904 solvent Substances 0.000 claims description 44
- VUHCPMIDSUGHNO-UHFFFAOYSA-N 6-methoxy-1,5-naphthyridin-4-amine Chemical compound N1=CC=C(N)C2=NC(OC)=CC=C21 VUHCPMIDSUGHNO-UHFFFAOYSA-N 0.000 claims description 43
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 38
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 37
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims description 34
- 208000015181 infectious disease Diseases 0.000 claims description 27
- SZHYPQDQYNLZJP-UHFFFAOYSA-N 3-oxo-4h-pyrido[3,2-b][1,4]thiazine-6-carboxylic acid Chemical compound S1CC(=O)NC2=NC(C(=O)O)=CC=C21 SZHYPQDQYNLZJP-UHFFFAOYSA-N 0.000 claims description 25
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 22
- DMBFCTCQROWGDZ-UHFFFAOYSA-N 8-aminoquinoline-2-carbonitrile Chemical compound C1=C(C#N)N=C2C(N)=CC=CC2=C1 DMBFCTCQROWGDZ-UHFFFAOYSA-N 0.000 claims description 20
- 229920002554 vinyl polymer Polymers 0.000 claims description 17
- 125000006355 carbonyl methylene group Chemical group [H]C([H])([*:2])C([*:1])=O 0.000 claims description 13
- 229940080818 propionamide Drugs 0.000 claims description 13
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 12
- 238000011282 treatment Methods 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims description 9
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims description 8
- 229940002612 prodrug Drugs 0.000 claims description 8
- 239000000651 prodrug Substances 0.000 claims description 8
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 claims description 7
- JHIAOWGCGNMQKA-UHFFFAOYSA-N 2-methyl-8-quinolinamine Chemical compound C1=CC=C(N)C2=NC(C)=CC=C21 JHIAOWGCGNMQKA-UHFFFAOYSA-N 0.000 claims description 6
- 125000005242 carbamoyl alkyl group Chemical group 0.000 claims description 6
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 6
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 5
- 125000005197 alkyl carbonyloxy alkyl group Chemical group 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- HDUOQGPJPLEPTI-KDOFPFPSSA-N (2s,5r)-5-(2,3-dihydro-[1,4]dioxino[2,3-c]pyridin-7-ylmethylamino)-n-(6-methoxy-1,5-naphthyridin-4-yl)oxane-2-carboxamide Chemical compound O1CCOC(C=N2)=C1C=C2CN[C@@H](CO1)CC[C@H]1C(=O)NC1=CC=NC2=CC=C(OC)N=C21 HDUOQGPJPLEPTI-KDOFPFPSSA-N 0.000 claims description 3
- RBNCELKPLQWOPL-KNQAVFIVSA-N (2s,5r)-n-(2-cyanoquinolin-8-yl)-5-(2,3-dihydro-1,4-benzodioxin-6-ylmethylamino)oxane-2-carboxamide Chemical compound O1CCOC2=CC(CN[C@@H]3CC[C@H](OC3)C(NC=3C4=NC(=CC=C4C=CC=3)C#N)=O)=CC=C21 RBNCELKPLQWOPL-KNQAVFIVSA-N 0.000 claims description 3
- SVAYVFWIEYFKAO-XLIONFOSSA-N (2s,5r)-n-(2-cyanoquinolin-8-yl)-5-(2,3-dihydro-[1,4]dioxino[2,3-c]pyridin-7-ylmethylamino)oxane-2-carboxamide Chemical compound O1CCOC(C=N2)=C1C=C2CN[C@@H](CO1)CC[C@H]1C(=O)NC1=CC=CC2=CC=C(C#N)N=C12 SVAYVFWIEYFKAO-XLIONFOSSA-N 0.000 claims description 3
- QQMWQCBLSYLUIU-MOPGFXCFSA-N (3r,6s)-n-(1-benzofuran-2-ylmethyl)-6-[(3-methoxyquinolin-5-yl)oxymethyl]oxan-3-amine Chemical compound C1=CC=C2OC(CN[C@@H]3CC[C@H](OC3)COC3=CC=CC4=NC=C(C=C43)OC)=CC2=C1 QQMWQCBLSYLUIU-MOPGFXCFSA-N 0.000 claims description 3
- MTTWQPKKDFKQPE-MSOLQXFVSA-N (3r,6s)-n-(1-benzofuran-2-ylmethyl)-6-[(6-methoxy-1,5-naphthyridin-4-yl)oxymethyl]oxan-3-amine Chemical compound C1=CC=C2OC(CN[C@@H]3CC[C@H](OC3)COC3=CC=NC4=CC=C(N=C43)OC)=CC2=C1 MTTWQPKKDFKQPE-MSOLQXFVSA-N 0.000 claims description 3
- WHCPNFUAESTIFK-QUCCMNQESA-N (3r,6s)-n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-6-[(6-methoxyquinolin-4-yl)oxymethyl]oxan-3-amine Chemical compound O1CCOC2=CC(CN[C@@H]3CC[C@H](OC3)COC3=CC=NC4=CC=C(C=C43)OC)=CC=C21 WHCPNFUAESTIFK-QUCCMNQESA-N 0.000 claims description 3
- XQPROHOFNUSWCG-APWZRJJASA-N (3r,6s)-n-(2,3-dihydro-[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)-6-[(6-methoxyquinolin-4-yl)oxymethyl]oxan-3-amine Chemical compound O1CCOC(C=N2)=C1C=C2CN[C@@H](CO1)CC[C@H]1COC1=CC=NC2=CC=C(OC)C=C21 XQPROHOFNUSWCG-APWZRJJASA-N 0.000 claims description 3
- RYJFLQNHKUSOSN-QUURXOELSA-N 2-[(2r,3r,6s)-3-(2,3-dihydro-1,4-benzodioxin-6-ylmethylamino)-6-[(6-methoxyquinolin-4-yl)oxymethyl]oxan-2-yl]ethanol Chemical compound O1CCOC2=CC(CN[C@@H]3CC[C@H](O[C@@H]3CCO)COC3=CC=NC4=CC=C(C=C43)OC)=CC=C21 RYJFLQNHKUSOSN-QUURXOELSA-N 0.000 claims description 3
- LZNFVGXESFCQMD-UHFFFAOYSA-N 3-[1-[2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]piperidin-3-yl]-n-(6-methoxy-1,5-naphthyridin-4-yl)propanamide Chemical compound O1CCOC2=CC(CCN3CCCC(C3)CCC(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 LZNFVGXESFCQMD-UHFFFAOYSA-N 0.000 claims description 3
- RPBQBSWZBRIJSO-UHFFFAOYSA-N 3-methoxyquinoxalin-5-amine Chemical compound C1=CC=C(N)C2=NC(OC)=CN=C21 RPBQBSWZBRIJSO-UHFFFAOYSA-N 0.000 claims description 3
- BHSRBGVGYNGPAV-UHFFFAOYSA-N 4-[3-[1-(1-benzofuran-2-ylmethyl)piperidin-3-yl]propoxy]-6-methoxyquinoline Chemical compound C1=CC=C2OC(CN3CCCC(C3)CCCOC3=CC=NC4=CC=C(C=C43)OC)=CC2=C1 BHSRBGVGYNGPAV-UHFFFAOYSA-N 0.000 claims description 3
- PTJPUAAPHWGXIK-SJORKVTESA-N 6-[[[(3r,6s)-6-[(3-methoxyquinolin-5-yl)oxymethyl]oxan-3-yl]amino]methyl]-4h-pyrido[3,2-b][1,4]thiazin-3-one Chemical compound S1CC(=O)NC2=NC(CN[C@@H]3CC[C@H](OC3)COC3=CC=CC4=NC=C(C=C43)OC)=CC=C21 PTJPUAAPHWGXIK-SJORKVTESA-N 0.000 claims description 3
- HWRPVSZEPDHAPX-SJORKVTESA-N 6-[[[(3r,6s)-6-[(6-methoxy-1,5-naphthyridin-4-yl)oxymethyl]oxan-3-yl]amino]methyl]-4h-1,4-benzothiazin-3-one Chemical compound S1CC(=O)NC2=CC(CN[C@@H]3CC[C@H](OC3)COC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 HWRPVSZEPDHAPX-SJORKVTESA-N 0.000 claims description 3
- WCUIUMSVLSFGOF-CVEARBPZSA-N 6-[[[(3r,6s)-6-[(6-methoxy-1,5-naphthyridin-4-yl)oxymethyl]oxan-3-yl]amino]methyl]-4h-pyrido[3,2-b][1,4]thiazin-3-one Chemical compound S1CC(=O)NC2=NC(CN[C@@H]3CC[C@H](OC3)COC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 WCUIUMSVLSFGOF-CVEARBPZSA-N 0.000 claims description 3
- AEXGVGHPHQYFRY-WBVHZDCISA-N 6-[[[(3r,6s)-6-[(6-methoxyquinazolin-4-yl)oxymethyl]oxan-3-yl]amino]methyl]-4h-pyrido[3,2-b][1,4]thiazin-3-one Chemical compound S1CC(=O)NC2=NC(CN[C@@H]3CC[C@H](OC3)COC3=NC=NC4=CC=C(C=C43)OC)=CC=C21 AEXGVGHPHQYFRY-WBVHZDCISA-N 0.000 claims description 3
- OVLUIXMXFMKOQJ-MJGOQNOKSA-N 6-[[[(3r,6s)-6-[(6-methoxyquinolin-4-yl)oxymethyl]oxan-3-yl]amino]methyl]-4h-1,4-benzoxazin-3-one Chemical compound O1CC(=O)NC2=CC(CN[C@@H]3CC[C@H](OC3)COC3=CC=NC4=CC=C(C=C43)OC)=CC=C21 OVLUIXMXFMKOQJ-MJGOQNOKSA-N 0.000 claims description 3
- CWWJQTNVNHKOSQ-CVEARBPZSA-N COC1=NC2=C(C=CC=C2C=C1)OC[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O Chemical compound COC1=NC2=C(C=CC=C2C=C1)OC[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O CWWJQTNVNHKOSQ-CVEARBPZSA-N 0.000 claims description 3
- ATPPWLOWFZEMHD-RTBURBONSA-N COC=1C=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound COC=1C=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O ATPPWLOWFZEMHD-RTBURBONSA-N 0.000 claims description 3
- XYSAVGPMHCKSAR-IAGOWNOFSA-N COC=1C=C2C(=NC=NC2=CC1)CC[C@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound COC=1C=C2C(=NC=NC2=CC1)CC[C@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O XYSAVGPMHCKSAR-IAGOWNOFSA-N 0.000 claims description 3
- AEXGVGHPHQYFRY-DOTOQJQBSA-N COC=1C=C2C(=NC=NC2=CC1)OC[C@H]1CC[C@@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound COC=1C=C2C(=NC=NC2=CC1)OC[C@H]1CC[C@@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O AEXGVGHPHQYFRY-DOTOQJQBSA-N 0.000 claims description 3
- FMAWDHIQMGGYBO-IAGOWNOFSA-N COC=1C=NC2=CC=CC(=C2C1)CC[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O Chemical compound COC=1C=NC2=CC=CC(=C2C1)CC[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O FMAWDHIQMGGYBO-IAGOWNOFSA-N 0.000 claims description 3
- QIBNEPIANRVOMQ-RTBURBONSA-N COC=1C=NC2=CC=CC(=C2C1)CC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O Chemical compound COC=1C=NC2=CC=CC(=C2C1)CC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O QIBNEPIANRVOMQ-RTBURBONSA-N 0.000 claims description 3
- KWVGEELOIPGDKQ-DLBZAZTESA-N COC=1C=NC2=CC=CC(=C2C1)OC[C@H]1CC[C@@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O Chemical compound COC=1C=NC2=CC=CC(=C2C1)OC[C@H]1CC[C@@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O KWVGEELOIPGDKQ-DLBZAZTESA-N 0.000 claims description 3
- VPQIRDWKIZGQOY-KGLIPLIRSA-N COC=1C=NC2=CC=CC(=C2N1)OC[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O Chemical compound COC=1C=NC2=CC=CC(=C2N1)OC[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O VPQIRDWKIZGQOY-KGLIPLIRSA-N 0.000 claims description 3
- AEQXXIILHBADBJ-UXHICEINSA-N O1CCOC2=C1C=CC(=C2)CN[C@@H]2CC[C@H](OC2)COC2=CC=NC1=CC=C(C=C21)C#N Chemical compound O1CCOC2=C1C=CC(=C2)CN[C@@H]2CC[C@H](OC2)COC2=CC=NC1=CC=C(C=C21)C#N AEQXXIILHBADBJ-UXHICEINSA-N 0.000 claims description 3
- OHNMCTWSCQOFCN-RBUKOAKNSA-N O1CCOC2=C1C=CC(=C2)CN[C@@H]2CN[C@H](CC2)COC2=CC=NC1=CC=C(C=C21)OC Chemical compound O1CCOC2=C1C=CC(=C2)CN[C@@H]2CN[C@H](CC2)COC2=CC=NC1=CC=C(C=C21)OC OHNMCTWSCQOFCN-RBUKOAKNSA-N 0.000 claims description 3
- MYPZKWCGYXZNTO-MJGOQNOKSA-N O1CCOC=2C=NC(=CC21)CN[C@@H]2CC[C@H](OC2)COC2=CC=NC1=CC=C(C=C21)C#N Chemical compound O1CCOC=2C=NC(=CC21)CN[C@@H]2CC[C@H](OC2)COC2=CC=NC1=CC=C(C=C21)C#N MYPZKWCGYXZNTO-MJGOQNOKSA-N 0.000 claims description 3
- MSXVXQWGTVSUIB-MOPGFXCFSA-N O=C1CSC2=C(N1)C=C(C=C2)CN[C@@H]2CC[C@H](OC2)COC2=CC=NC1=CC=C(C=C21)C#N Chemical compound O=C1CSC2=C(N1)C=C(C=C2)CN[C@@H]2CC[C@H](OC2)COC2=CC=NC1=CC=C(C=C21)C#N MSXVXQWGTVSUIB-MOPGFXCFSA-N 0.000 claims description 3
- LTQGLQZWHUZZEH-UXHICEINSA-N O=C1CSC2=C(N1)C=C(C=C2)CN[C@@H]2CC[C@H](OC2)COC=2C=CC=C1C=CC(=NC21)C#N Chemical compound O=C1CSC2=C(N1)C=C(C=C2)CN[C@@H]2CC[C@H](OC2)COC=2C=CC=C1C=CC(=NC21)C#N LTQGLQZWHUZZEH-UXHICEINSA-N 0.000 claims description 3
- NXZWJBZJNOQDKM-MOPGFXCFSA-N O=C1NC2=C(OC1)C=CC(=N2)CN[C@@H]2CC[C@H](OC2)COC=2C=CC=C1C=CC(=NC21)C#N Chemical compound O=C1NC2=C(OC1)C=CC(=N2)CN[C@@H]2CC[C@H](OC2)COC=2C=CC=C1C=CC(=NC21)C#N NXZWJBZJNOQDKM-MOPGFXCFSA-N 0.000 claims description 3
- VYSHPDAPBQAUQL-BUJZBAMKSA-N OC(CC1=CC=NC2=CC=C(C=C12)OC)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O Chemical compound OC(CC1=CC=NC2=CC=C(C=C12)OC)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O VYSHPDAPBQAUQL-BUJZBAMKSA-N 0.000 claims description 3
- GQHWTIXRWHXHSB-OIYBAANXSA-N OC(C[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O)C1=C2C=C(C=NC2=CC=C1)OC Chemical compound OC(C[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O)C1=C2C=C(C=NC2=CC=C1)OC GQHWTIXRWHXHSB-OIYBAANXSA-N 0.000 claims description 3
- ILPPLMBJCXRLGK-WTNAPCKOSA-N O[C@@H](CC1=C2C=C(C=NC2=CC=C1)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O Chemical compound O[C@@H](CC1=C2C=C(C=NC2=CC=C1)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O ILPPLMBJCXRLGK-WTNAPCKOSA-N 0.000 claims description 3
- NGRPYWAJHHTWDY-JLSDUUJJSA-N O[C@@H](CC1=CC=NC2=CC=C(N=C12)OC)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@@H](CC1=CC=NC2=CC=C(N=C12)OC)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O NGRPYWAJHHTWDY-JLSDUUJJSA-N 0.000 claims description 3
- XQDGBWSKWGOWMB-JLHGSKIFSA-N O[C@@H](C[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)C1=C2C=C(C=NC2=CC=C1)OC Chemical compound O[C@@H](C[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)C1=C2C=C(C=NC2=CC=C1)OC XQDGBWSKWGOWMB-JLHGSKIFSA-N 0.000 claims description 3
- LVENNDOAFOASBT-KAOJSAQUSA-N O[C@@H]([C@H]([C@H]1OC[C@@H](CC1)NCC=1C=CC=2OCC(NC2N1)=O)O)C=1C=CC=C2C=CC(=NC12)C#N Chemical compound O[C@@H]([C@H]([C@H]1OC[C@@H](CC1)NCC=1C=CC=2OCC(NC2N1)=O)O)C=1C=CC=C2C=CC(=NC12)C#N LVENNDOAFOASBT-KAOJSAQUSA-N 0.000 claims description 3
- UUCVTRRTVDNJBI-YHYVQYDKSA-N O[C@H](CC1=CC=NC2=CC=C(C=C12)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CS2)=O)N1 Chemical compound O[C@H](CC1=CC=NC2=CC=C(C=C12)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CS2)=O)N1 UUCVTRRTVDNJBI-YHYVQYDKSA-N 0.000 claims description 3
- HPAZHEGIKZGDCM-RIJOHQFPSA-N O[C@H]([C@@H](C1=CC=NC2=CC=C(C=C12)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@H]([C@@H](C1=CC=NC2=CC=C(C=C12)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O HPAZHEGIKZGDCM-RIJOHQFPSA-N 0.000 claims description 3
- GUEBWQFTJDQZMH-HRULMYSOSA-N O[C@H]([C@@H](C1=CC=NC2=CC=C(N=C12)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@H]([C@@H](C1=CC=NC2=CC=C(N=C12)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O GUEBWQFTJDQZMH-HRULMYSOSA-N 0.000 claims description 3
- MXOGTYQAGALOTH-HRULMYSOSA-N O[C@H]([C@@H](C=1C=CC=C2C=CC(=NC12)OC)O)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@H]([C@@H](C=1C=CC=C2C=CC(=NC12)OC)O)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O MXOGTYQAGALOTH-HRULMYSOSA-N 0.000 claims description 3
- BCJXHIWTCHGWSA-WTYSZDEDSA-N O[C@H]1[C@H](CO[C@@H]([C@H]1O)COC1=CC=NC2=CC=C(C=C12)OC)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@H]1[C@H](CO[C@@H]([C@H]1O)COC1=CC=NC2=CC=C(C=C12)OC)NCC=1C=CC=2SCC(NC2N1)=O BCJXHIWTCHGWSA-WTYSZDEDSA-N 0.000 claims description 3
- 230000000877 morphologic effect Effects 0.000 claims description 3
- DNTKPTHXBAUFRF-UHFFFAOYSA-N n-(6-methoxy-1,5-naphthyridin-4-yl)-3-[[(3-oxo-4h-1,4-benzoxazin-6-yl)methylamino]methyl]cyclohexane-1-carboxamide Chemical compound O1CC(=O)NC2=CC(CNCC3CCCC(C3)C(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 DNTKPTHXBAUFRF-UHFFFAOYSA-N 0.000 claims description 3
- YSLXFQSRWDUXGB-PJFJWIBOSA-N n-[(3r,6s)-6-[(1r,2r)-1,2-dihydroxy-2-(6-methoxy-1,5-naphthyridin-4-yl)ethyl]oxan-3-yl]-3-oxo-4h-pyrido[3,2-b][1,4]thiazine-6-carboxamide Chemical compound S1CC(=O)NC2=NC(C(=O)N[C@@H]3CC[C@H](OC3)[C@H](O)[C@H](O)C3=CC=NC4=CC=C(N=C43)OC)=CC=C21 YSLXFQSRWDUXGB-PJFJWIBOSA-N 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 229910052727 yttrium Inorganic materials 0.000 claims description 3
- NLSHAPAVFKIXSZ-KNQAVFIVSA-N (2s,5r)-5-(2,3-dihydro-1,4-benzodioxin-6-ylmethylamino)-n-(2-methylquinolin-8-yl)oxane-2-carboxamide Chemical compound O1CCOC2=CC(CN[C@@H]3CC[C@H](OC3)C(=O)NC3=CC=CC4=CC=C(N=C43)C)=CC=C21 NLSHAPAVFKIXSZ-KNQAVFIVSA-N 0.000 claims description 2
- ASXDGVMSEWRJEY-UZLBHIALSA-N (2s,5r)-5-(2,3-dihydro-1,4-benzodioxin-6-ylmethylamino)-n-(6-methoxy-1,5-naphthyridin-4-yl)oxane-2-carboxamide Chemical compound O1CCOC2=CC(CN[C@@H]3CC[C@H](OC3)C(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 ASXDGVMSEWRJEY-UZLBHIALSA-N 0.000 claims description 2
- CFRRQWGAIUPWII-QAPCUYQASA-N (2s,5r)-5-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-ylmethylamino)-n-(6-methoxy-1,5-naphthyridin-4-yl)oxane-2-carboxamide Chemical compound O1CCOC2=NC(CN[C@@H]3CC[C@H](OC3)C(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 CFRRQWGAIUPWII-QAPCUYQASA-N 0.000 claims description 2
- CYSOBIIWPHOJJW-BEFAXECRSA-N (2s,5r)-n-(6-methoxy-1,5-naphthyridin-4-yl)-5-[(3-oxo-4h-1,4-benzothiazin-6-yl)methylamino]oxane-2-carboxamide Chemical compound S1CC(=O)NC2=CC(CN[C@@H]3CC[C@H](OC3)C(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 CYSOBIIWPHOJJW-BEFAXECRSA-N 0.000 claims description 2
- NDXWAAKFUDDIDP-PBHICJAKSA-N (2s,5r)-n-(6-methoxy-1,5-naphthyridin-4-yl)-5-[(3-oxo-4h-pyrido[3,2-b][1,4]thiazin-6-yl)methylamino]oxane-2-carboxamide Chemical compound S1CC(=O)NC2=NC(CN[C@@H]3CC[C@H](OC3)C(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 NDXWAAKFUDDIDP-PBHICJAKSA-N 0.000 claims description 2
- LMFVVLYOLHYBBD-MSOLQXFVSA-N (3r,6s)-n-(1,3-benzodioxol-5-ylmethyl)-6-[(3-methoxyquinolin-5-yl)oxymethyl]oxan-3-amine Chemical compound C1=C2OCOC2=CC(CN[C@@H]2CC[C@H](OC2)COC2=CC=CC3=NC=C(C=C32)OC)=C1 LMFVVLYOLHYBBD-MSOLQXFVSA-N 0.000 claims description 2
- ZEGPOKVBOWHBQZ-MSOLQXFVSA-N (3r,6s)-n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-6-[(3-methoxyquinoxalin-5-yl)oxymethyl]oxan-3-amine Chemical compound O1CCOC2=CC(CN[C@@H]3CC[C@H](OC3)COC3=CC=CC4=NC=C(N=C43)OC)=CC=C21 ZEGPOKVBOWHBQZ-MSOLQXFVSA-N 0.000 claims description 2
- PPOCOOYVVOOWMT-MSOLQXFVSA-N (3r,6s)-n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-6-[(6-methoxy-1,5-naphthyridin-4-yl)oxymethyl]oxan-3-amine Chemical compound O1CCOC2=CC(CN[C@@H]3CC[C@H](OC3)COC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 PPOCOOYVVOOWMT-MSOLQXFVSA-N 0.000 claims description 2
- OZPJIRXJDSOKHR-QUCCMNQESA-N (3r,6s)-n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-6-[(6-methoxyquinolin-4-yl)oxymethyl]-3,6-dihydro-2h-pyran-3-amine Chemical compound O1CCOC2=CC(CN[C@H]3CO[C@@H](C=C3)COC3=CC=NC4=CC=C(C=C43)OC)=CC=C21 OZPJIRXJDSOKHR-QUCCMNQESA-N 0.000 claims description 2
- SAWUQEVPMWWDHE-MJGOQNOKSA-N (3r,6s)-n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-6-[[6-(trifluoromethoxy)quinolin-4-yl]oxymethyl]oxan-3-amine Chemical compound O1CCOC2=CC(CN[C@@H]3CC[C@H](OC3)COC3=CC=NC4=CC=C(C=C43)OC(F)(F)F)=CC=C21 SAWUQEVPMWWDHE-MJGOQNOKSA-N 0.000 claims description 2
- KDCAIBUOMHEPKC-MSOLQXFVSA-N (3r,6s)-n-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-ylmethyl)-6-[(3-methoxyquinolin-5-yl)oxymethyl]oxan-3-amine Chemical compound O1CCOC2=NC(CN[C@@H]3CC[C@H](OC3)COC3=CC=CC4=NC=C(C=C43)OC)=CC=C21 KDCAIBUOMHEPKC-MSOLQXFVSA-N 0.000 claims description 2
- HMMSQLZOPRDAJE-AEFFLSMTSA-N (3r,6s)-n-(2,3-dihydro-[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)-6-[(3-methoxyquinolin-5-yl)oxymethyl]oxan-3-amine Chemical compound O1CCOC(C=N2)=C1C=C2CN[C@@H](CO1)CC[C@H]1COC1=CC=CC2=NC=C(OC)C=C21 HMMSQLZOPRDAJE-AEFFLSMTSA-N 0.000 claims description 2
- FHQAGCWZHWRWJT-MOPGFXCFSA-N (3r,6s)-n-heptyl-6-[(3-methoxyquinolin-5-yl)oxymethyl]oxan-3-amine Chemical compound O1C[C@H](NCCCCCCC)CC[C@H]1COC1=CC=CC2=NC=C(OC)C=C12 FHQAGCWZHWRWJT-MOPGFXCFSA-N 0.000 claims description 2
- ZGRCWCPMDGISKX-UHFFFAOYSA-N 2-[1-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)piperidin-3-yl]oxy-n-(6-methoxy-1,5-naphthyridin-4-yl)acetamide Chemical compound O1CCOC2=CC(CN3CCCC(C3)OCC(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 ZGRCWCPMDGISKX-UHFFFAOYSA-N 0.000 claims description 2
- ZKBBMFIMKAPUCN-CABCVRRESA-N 2-[[(3r,6s)-6-[(3-methoxyquinolin-5-yl)oxymethyl]oxan-3-yl]amino]-n-(1,3-thiazol-2-yl)acetamide Chemical compound N([C@@H]1CC[C@H](OC1)COC1=CC=CC2=NC=C(C=C21)OC)CC(=O)NC1=NC=CS1 ZKBBMFIMKAPUCN-CABCVRRESA-N 0.000 claims description 2
- PAVSNJAWHNZAMQ-UHFFFAOYSA-N 3-[(2,3-dihydro-1,4-benzodioxin-6-ylmethylamino)methyl]-n-(2-methylquinolin-8-yl)cyclohexane-1-carboxamide Chemical compound O1CCOC2=CC(CNCC3CCCC(C3)C(=O)NC3=CC=CC4=CC=C(N=C43)C)=CC=C21 PAVSNJAWHNZAMQ-UHFFFAOYSA-N 0.000 claims description 2
- IBKNBOIAZHYDGT-UHFFFAOYSA-N 3-[(2,3-dihydro-1,4-benzodioxin-6-ylmethylamino)methyl]-n-(6-methoxy-1,5-naphthyridin-4-yl)cyclohexane-1-carboxamide Chemical compound O1CCOC2=CC(CNCC3CCCC(C3)C(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 IBKNBOIAZHYDGT-UHFFFAOYSA-N 0.000 claims description 2
- LWQFODXSZNXRJK-UHFFFAOYSA-N 3-[1-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)piperidin-3-yl]-n-(6-methoxy-1,5-naphthyridin-4-yl)propanamide Chemical compound O1CCOC2=CC(CN3CCCC(C3)CCC(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 LWQFODXSZNXRJK-UHFFFAOYSA-N 0.000 claims description 2
- HNIMHFWNYYXONH-UHFFFAOYSA-N 3-[1-(2,3-dihydro-[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)piperidin-3-yl]-n-(6-methoxy-1,5-naphthyridin-4-yl)propanamide Chemical compound O1CCOC(C=N2)=C1C=C2CN(C1)CCCC1CCC(=O)NC1=CC=NC2=CC=C(OC)N=C21 HNIMHFWNYYXONH-UHFFFAOYSA-N 0.000 claims description 2
- NOFPZXGKTSMGJF-UHFFFAOYSA-N 3-chloro-6-methoxyquinolin-4-amine Chemical compound N1=CC(Cl)=C(N)C2=CC(OC)=CC=C21 NOFPZXGKTSMGJF-UHFFFAOYSA-N 0.000 claims description 2
- GJSZXSXYEKSOAN-UHFFFAOYSA-N 3-oxo-4h-pyrido[3,2-b][1,4]oxazine-6-carboxylic acid Chemical compound O1CC(=O)NC2=NC(C(=O)O)=CC=C21 GJSZXSXYEKSOAN-UHFFFAOYSA-N 0.000 claims description 2
- SGJJRJCYWAKOAB-UHFFFAOYSA-N 4-[3-[1-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)piperidin-3-yl]propoxy]-6-methoxyquinoline Chemical compound O1CCOC2=CC(CN3CCCC(C3)CCCOC3=CC=NC4=CC=C(C=C43)OC)=CC=C21 SGJJRJCYWAKOAB-UHFFFAOYSA-N 0.000 claims description 2
- CMLHTKOGKFIPGZ-UWUFEASWSA-N 6-[[[(2r,3r,6s)-2-(2-hydroxyethyl)-6-[(6-methoxyquinolin-4-yl)oxymethyl]oxan-3-yl]amino]methyl]-4h-1,4-benzothiazin-3-one Chemical compound S1CC(=O)NC2=CC(CN[C@@H]3CC[C@H](O[C@@H]3CCO)COC3=CC=NC4=CC=C(C=C43)OC)=CC=C21 CMLHTKOGKFIPGZ-UWUFEASWSA-N 0.000 claims description 2
- IQKKKNWAXDCTCY-QTGUNEKASA-N 6-[[[(2r,3r,6s)-2-(2-hydroxyethyl)-6-[(6-methoxyquinolin-4-yl)oxymethyl]oxan-3-yl]amino]methyl]-4h-pyrido[3,2-b][1,4]thiazin-3-one Chemical compound S1CC(=O)NC2=NC(CN[C@@H]3CC[C@H](O[C@@H]3CCO)COC3=CC=NC4=CC=C(C=C43)OC)=CC=C21 IQKKKNWAXDCTCY-QTGUNEKASA-N 0.000 claims description 2
- XTVIZXPGQNSAAD-CSMHICIZSA-N 6-[[[(3r,6s)-6-[(1r,2r)-1,2-dihydroxy-2-(2-methoxyquinolin-8-yl)ethyl]oxan-3-yl]amino]methyl]-4h-pyrido[3,2-b][1,4]thiazin-3-one Chemical compound S1CC(=O)NC2=NC(CN[C@@H]3CC[C@H](OC3)[C@H](O)[C@H](O)C3=CC=CC4=CC=C(N=C43)OC)=CC=C21 XTVIZXPGQNSAAD-CSMHICIZSA-N 0.000 claims description 2
- HPAZHEGIKZGDCM-VGRWIXQOSA-N 6-[[[(3r,6s)-6-[(1s,2r)-1,2-dihydroxy-2-(6-methoxyquinolin-4-yl)ethyl]oxan-3-yl]amino]methyl]-4h-pyrido[3,2-b][1,4]thiazin-3-one Chemical compound S1CC(=O)NC2=NC(CN[C@@H]3CC[C@H](OC3)[C@@H](O)[C@H](O)C3=CC=NC4=CC=C(C=C43)OC)=CC=C21 HPAZHEGIKZGDCM-VGRWIXQOSA-N 0.000 claims description 2
- WOSIYXPSRDAHOI-MSOLQXFVSA-N 6-[[[(3r,6s)-6-[(3-methoxyquinolin-5-yl)oxymethyl]oxan-3-yl]amino]methyl]-4h-1,4-benzothiazin-3-one Chemical compound S1CC(=O)NC2=CC(CN[C@@H]3CC[C@H](OC3)COC3=CC=CC4=NC=C(C=C43)OC)=CC=C21 WOSIYXPSRDAHOI-MSOLQXFVSA-N 0.000 claims description 2
- YWEFMXBVACFMCK-CVEARBPZSA-N 6-[[[(3r,6s)-6-[(3-methoxyquinoxalin-5-yl)oxymethyl]oxan-3-yl]amino]methyl]-4h-pyrido[3,2-b][1,4]thiazin-3-one Chemical compound S1CC(=O)NC2=NC(CN[C@@H]3CC[C@H](OC3)COC3=CC=CC4=NC=C(N=C43)OC)=CC=C21 YWEFMXBVACFMCK-CVEARBPZSA-N 0.000 claims description 2
- DNQJIVPVXXMIAB-SJORKVTESA-N 6-[[[(3r,6s)-6-[(6-methoxy-1,5-naphthyridin-4-yl)oxymethyl]oxan-3-yl]amino]methyl]-4h-1,4-benzoxazin-3-one Chemical compound O1CC(=O)NC2=CC(CN[C@@H]3CC[C@H](OC3)COC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 DNQJIVPVXXMIAB-SJORKVTESA-N 0.000 claims description 2
- DKTDHDPYNQPZNO-MJGOQNOKSA-N 6-[[[(3r,6s)-6-[(6-methoxyquinolin-4-yl)oxymethyl]oxan-3-yl]amino]methyl]-4h-1,4-benzothiazin-3-one Chemical compound S1CC(=O)NC2=CC(CN[C@@H]3CC[C@H](OC3)COC3=CC=NC4=CC=C(C=C43)OC)=CC=C21 DKTDHDPYNQPZNO-MJGOQNOKSA-N 0.000 claims description 2
- OLCCWRYDKCOIAL-WBVHZDCISA-N 6-[[[(3r,6s)-6-[[6-(difluoromethoxy)quinolin-4-yl]oxymethyl]oxan-3-yl]amino]methyl]-4h-pyrido[3,2-b][1,4]thiazin-3-one Chemical compound S1CC(=O)NC2=NC(CN[C@@H]3CC[C@H](OC3)COC3=CC=NC4=CC=C(C=C43)OC(F)F)=CC=C21 OLCCWRYDKCOIAL-WBVHZDCISA-N 0.000 claims description 2
- ZQWVTCAOLQPPQD-UHFFFAOYSA-N 6-[[[6-[2-(8-fluoro-6-methoxyquinolin-4-yl)ethenyl]oxan-3-yl]amino]methyl]-4h-pyrido[3,2-b][1,4]thiazin-3-one Chemical compound S1CC(=O)NC2=NC(CNC3CCC(OC3)C=CC3=CC=NC4=C(F)C=C(C=C43)OC)=CC=C21 ZQWVTCAOLQPPQD-UHFFFAOYSA-N 0.000 claims description 2
- YBERECHIVRYUAI-UHFFFAOYSA-N 8-[[5-[(3-oxo-4h-pyrido[3,2-b][1,4]thiazin-6-yl)methylamino]oxan-2-yl]methoxy]quinoline-2-carbonitrile Chemical compound C1=C(C#N)N=C2C(OCC3CCC(CO3)NCC3=CC=C4SCC(NC4=N3)=O)=CC=CC2=C1 YBERECHIVRYUAI-UHFFFAOYSA-N 0.000 claims description 2
- WENZVMLSLXVYFK-CVEARBPZSA-N C(#N)C=1C=C2C(=CC=NC2=CC1)OC[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O Chemical compound C(#N)C=1C=C2C(=CC=NC2=CC1)OC[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O WENZVMLSLXVYFK-CVEARBPZSA-N 0.000 claims description 2
- NYBKCOUHYPDPPK-VQTJNVASSA-N C(C)(C)(C)OC(CN1[C@H](CC[C@@H](C1)NCC=1C=CC=2SCC(NC2N1)=O)COC1=NC=NC2=CC=C(C=C12)OC)=O Chemical compound C(C)(C)(C)OC(CN1[C@H](CC[C@@H](C1)NCC=1C=CC=2SCC(NC2N1)=O)COC1=NC=NC2=CC=C(C=C12)OC)=O NYBKCOUHYPDPPK-VQTJNVASSA-N 0.000 claims description 2
- NZVLXFXCDWJNRE-YGOYIFOWSA-N C(CCCCCC)N[C@@H]1CC[C@H](OC1)[C@H](CC1=CC=NC2=CC=C(C=C12)OC)O Chemical compound C(CCCCCC)N[C@@H]1CC[C@H](OC1)[C@H](CC1=CC=NC2=CC=C(C=C12)OC)O NZVLXFXCDWJNRE-YGOYIFOWSA-N 0.000 claims description 2
- UZRUMQUUKVUMDW-MSOLQXFVSA-N COC1=NC2=C(C=CC=C2C=C1)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound COC1=NC2=C(C=CC=C2C=C1)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O UZRUMQUUKVUMDW-MSOLQXFVSA-N 0.000 claims description 2
- XVJNPQMIRQWLFC-WOJBJXKFSA-N COC=1C=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1 Chemical compound COC=1C=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1 XVJNPQMIRQWLFC-WOJBJXKFSA-N 0.000 claims description 2
- WUGPTXGNLUHJRB-AEFFLSMTSA-N COC=1C=C2C(=CC=NC2=CC1)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound COC=1C=C2C(=CC=NC2=CC1)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O WUGPTXGNLUHJRB-AEFFLSMTSA-N 0.000 claims description 2
- LESIVGFMPJUVNX-QZTJIDSGSA-N COC=1C=C2C(=NC=NC2=CC1)CC[C@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CS2)=O)C1 Chemical compound COC=1C=C2C(=NC=NC2=CC1)CC[C@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CS2)=O)C1 LESIVGFMPJUVNX-QZTJIDSGSA-N 0.000 claims description 2
- URUTUUJBQUGCPL-GOEBONIOSA-N COC=1C=C2C(=NC=NC2=CC1)OC[C@H]1CC[C@@H](CN1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound COC=1C=C2C(=NC=NC2=CC1)OC[C@H]1CC[C@@H](CN1)NCC=1C=CC=2SCC(NC2N1)=O URUTUUJBQUGCPL-GOEBONIOSA-N 0.000 claims description 2
- BAXJPLXKCSTEDE-RTBURBONSA-N COC=1C=NC2=CC=CC(=C2C1)CC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound COC=1C=NC2=CC=CC(=C2C1)CC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O BAXJPLXKCSTEDE-RTBURBONSA-N 0.000 claims description 2
- PTJPUAAPHWGXIK-DLBZAZTESA-N COC=1C=NC2=CC=CC(=C2C1)OC[C@H]1CC[C@@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound COC=1C=NC2=CC=CC(=C2C1)OC[C@H]1CC[C@@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O PTJPUAAPHWGXIK-DLBZAZTESA-N 0.000 claims description 2
- YRYPACDGLFWWFS-SJORKVTESA-N COC=1C=NC2=CC=CC(=C2N1)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1 Chemical compound COC=1C=NC2=CC=CC(=C2N1)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1 YRYPACDGLFWWFS-SJORKVTESA-N 0.000 claims description 2
- CDEUGRFKSMHFPK-SJORKVTESA-N COC=1C=NC2=CC=CC(=C2N1)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CS2)=O)C1 Chemical compound COC=1C=NC2=CC=CC(=C2N1)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CS2)=O)C1 CDEUGRFKSMHFPK-SJORKVTESA-N 0.000 claims description 2
- AOPZIKXHKZPEHC-CVEARBPZSA-N COC=1C=NC2=CC=CC(=C2N1)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O Chemical compound COC=1C=NC2=CC=CC(=C2N1)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O AOPZIKXHKZPEHC-CVEARBPZSA-N 0.000 claims description 2
- VNUMSGHONBCNFR-HZPDHXFCSA-N COC=1N=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O Chemical compound COC=1N=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O VNUMSGHONBCNFR-HZPDHXFCSA-N 0.000 claims description 2
- TXWGYTCAELHIOO-RTBURBONSA-N COC=1N=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CS2)=O)C1 Chemical compound COC=1N=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CS2)=O)C1 TXWGYTCAELHIOO-RTBURBONSA-N 0.000 claims description 2
- PMNUMXMRYRCGAD-IRXDYDNUSA-N COC=1N=C2C(=CC=NC2=CC1)CC[C@H]1CC[C@@H](CN1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound COC=1N=C2C(=CC=NC2=CC1)CC[C@H]1CC[C@@H](CN1)NCC=1C=CC=2SCC(NC2N1)=O PMNUMXMRYRCGAD-IRXDYDNUSA-N 0.000 claims description 2
- AKFJAZJFTWVTLG-QFBILLFUSA-N COC=1N=C2C(=CC=NC2=CC1)NC(=O)[C@@H]1NC[C@H](CC1)NCC1=CC2=C(OCCO2)C=C1 Chemical compound COC=1N=C2C(=CC=NC2=CC1)NC(=O)[C@@H]1NC[C@H](CC1)NCC1=CC2=C(OCCO2)C=C1 AKFJAZJFTWVTLG-QFBILLFUSA-N 0.000 claims description 2
- MQOAHXYINJFQIW-SUMWQHHRSA-N COC=1N=C2C(=CC=NC2=CC1)NC(=O)[C@@H]1NC[C@H](CC1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound COC=1N=C2C(=CC=NC2=CC1)NC(=O)[C@@H]1NC[C@H](CC1)NCC=1C=CC=2SCC(NC2N1)=O MQOAHXYINJFQIW-SUMWQHHRSA-N 0.000 claims description 2
- ZHLREKUJEDPHPP-WBVHZDCISA-N COc1ccc2ncnc(OC[C@H]3OC[C@H](NCc4ccc5SCC(=O)Nc5n4)C=C3)c2c1 Chemical compound COc1ccc2ncnc(OC[C@H]3OC[C@H](NCc4ccc5SCC(=O)Nc5n4)C=C3)c2c1 ZHLREKUJEDPHPP-WBVHZDCISA-N 0.000 claims description 2
- YFXJNPPREGTZRC-RTBURBONSA-N FC1=C(C=C(C=C1)F)NC(CN[C@H]1CO[C@@H](CC1)CCC1=CC=NC2=CC=C(C=C12)OC)=O Chemical compound FC1=C(C=C(C=C1)F)NC(CN[C@H]1CO[C@@H](CC1)CCC1=CC=NC2=CC=C(C=C12)OC)=O YFXJNPPREGTZRC-RTBURBONSA-N 0.000 claims description 2
- RPZKLORZJGAGKW-MSOLQXFVSA-N FC=1C=C(C=C2C(=CC=NC12)CC[C@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)OC Chemical compound FC=1C=C(C=C2C(=CC=NC12)CC[C@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)OC RPZKLORZJGAGKW-MSOLQXFVSA-N 0.000 claims description 2
- ZQIHHXNDDGZUKO-CVEARBPZSA-N FC=1C=C(C=C2C(=CC=NC12)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O)OC Chemical compound FC=1C=C(C=C2C(=CC=NC12)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O)OC ZQIHHXNDDGZUKO-CVEARBPZSA-N 0.000 claims description 2
- ZTCVXTFFIFDOBT-SGLUODAXSA-N FC=1C=C(C=C2C(=CC=NC12)[C@H]([C@@H](O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O)O)OC Chemical compound FC=1C=C(C=C2C(=CC=NC12)[C@H]([C@@H](O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O)O)OC ZTCVXTFFIFDOBT-SGLUODAXSA-N 0.000 claims description 2
- LLQPQVKOKNNJSR-LDBYXDLTSA-N FC=1C=NC2=CC=C(C=C2C1[C@@H](C[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)O)OC Chemical compound FC=1C=NC2=CC=C(C=C2C1[C@@H](C[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)O)OC LLQPQVKOKNNJSR-LDBYXDLTSA-N 0.000 claims description 2
- UNTFBOBIPRLKSB-UHFFFAOYSA-N Fc1ccc2nccc(OCC3CCC(CO3)NCc3ccc4SCC(=O)Nc4n3)c2c1 Chemical compound Fc1ccc2nccc(OCC3CCC(CO3)NCc3ccc4SCC(=O)Nc4n3)c2c1 UNTFBOBIPRLKSB-UHFFFAOYSA-N 0.000 claims description 2
- 101001110286 Homo sapiens Ras-related C3 botulinum toxin substrate 1 Proteins 0.000 claims description 2
- RLUSDJXLRKIYNG-SJORKVTESA-N N1=C2C(=NS1)C=C(C=C2)CN[C@H]2CO[C@@H](CC2)COC2=C1C=C(C=NC1=CC=C2)OC Chemical compound N1=C2C(=NS1)C=C(C=C2)CN[C@H]2CO[C@@H](CC2)COC2=C1C=C(C=NC1=CC=C2)OC RLUSDJXLRKIYNG-SJORKVTESA-N 0.000 claims description 2
- OOZXUGTYNUKOKC-NUEBVZBTSA-N O1CCOC2=C1C=CC(=C2)CN[C@@H]2CC[C@H](OC2)C(CC2=CC=NC1=CC=C(C=C21)OC)O Chemical compound O1CCOC2=C1C=CC(=C2)CN[C@@H]2CC[C@H](OC2)C(CC2=CC=NC1=CC=C(C=C21)OC)O OOZXUGTYNUKOKC-NUEBVZBTSA-N 0.000 claims description 2
- UPHARAQTOPSVHM-ZWKOTPCHSA-N O1CCOC2=C1C=CC(=C2)CN[C@@H]2CN[C@H](CC2)COC2=NC=NC1=CC=C(C=C21)OC Chemical compound O1CCOC2=C1C=CC(=C2)CN[C@@H]2CN[C@H](CC2)COC2=NC=NC1=CC=C(C=C21)OC UPHARAQTOPSVHM-ZWKOTPCHSA-N 0.000 claims description 2
- AJRAAAKFLIDMJB-RBUKOAKNSA-N O1CCOC2=C1C=CC(=C2)CN[C@@H]2CO[C@H](CC2)COC2=C1C=C(C=NC1=CC=C2)OC Chemical compound O1CCOC2=C1C=CC(=C2)CN[C@@H]2CO[C@H](CC2)COC2=C1C=C(C=NC1=CC=C2)OC AJRAAAKFLIDMJB-RBUKOAKNSA-N 0.000 claims description 2
- UUCVTRRTVDNJBI-UCLFCPHBSA-N OC(CC1=CC=NC2=CC=C(C=C12)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CS2)=O)N1 Chemical compound OC(CC1=CC=NC2=CC=C(C=C12)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CS2)=O)N1 UUCVTRRTVDNJBI-UCLFCPHBSA-N 0.000 claims description 2
- JJPKPRAAXXNZCB-UCLFCPHBSA-N OC(CC1=CC=NC2=CC=C(C=C12)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O Chemical compound OC(CC1=CC=NC2=CC=C(C=C12)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O JJPKPRAAXXNZCB-UCLFCPHBSA-N 0.000 claims description 2
- LYXTWSVOAFQIIP-WDOSNPKHSA-N OC(CC1=CC=NC2=CC=C(N=C12)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound OC(CC1=CC=NC2=CC=C(N=C12)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O LYXTWSVOAFQIIP-WDOSNPKHSA-N 0.000 claims description 2
- CSOXKJDHQCWAMA-RMAOKOMNSA-N OC(C[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O)C1=CC=NC2=CC=C(N=C12)OC Chemical compound OC(C[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O)C1=CC=NC2=CC=C(N=C12)OC CSOXKJDHQCWAMA-RMAOKOMNSA-N 0.000 claims description 2
- JPDDCYHOSRYQQP-SFHLNBCPSA-N OCC[C@H]1O[C@@H](CC[C@H]1NCC=1C=CC=2SCC(NC2N1)=O)CCC1=CC=NC2=CC=C(N=C12)OC Chemical compound OCC[C@H]1O[C@@H](CC[C@H]1NCC=1C=CC=2SCC(NC2N1)=O)CCC1=CC=NC2=CC=C(N=C12)OC JPDDCYHOSRYQQP-SFHLNBCPSA-N 0.000 claims description 2
- LTPPKUUHHILXKQ-WTNAPCKOSA-N O[C@@H](CC1=C2C=C(C=NC2=CC=C1)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@@H](CC1=C2C=C(C=NC2=CC=C1)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O LTPPKUUHHILXKQ-WTNAPCKOSA-N 0.000 claims description 2
- VYSHPDAPBQAUQL-NQERJWCQSA-N O[C@@H](CC1=CC=NC2=CC=C(C=C12)OC)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@@H](CC1=CC=NC2=CC=C(C=C12)OC)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O VYSHPDAPBQAUQL-NQERJWCQSA-N 0.000 claims description 2
- WRTMKOZCEUQRLF-XARZLDAJSA-N O[C@@H](CC1=CC=NC2=CC=C(C=C12)OC)[C@@H]1CC[C@H](CO1)NCC1=CC2=C(OCC(N2)=O)C=N1 Chemical compound O[C@@H](CC1=CC=NC2=CC=C(C=C12)OC)[C@@H]1CC[C@H](CO1)NCC1=CC2=C(OCC(N2)=O)C=N1 WRTMKOZCEUQRLF-XARZLDAJSA-N 0.000 claims description 2
- UUCVTRRTVDNJBI-WTNAPCKOSA-N O[C@@H](CC1=CC=NC2=CC=C(C=C12)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@@H](CC1=CC=NC2=CC=C(C=C12)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O UUCVTRRTVDNJBI-WTNAPCKOSA-N 0.000 claims description 2
- GZFLUMCQCQYJQR-NEWSRXKRSA-N O[C@@H](CC1=CC=NC2=CC=C(N=C12)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O Chemical compound O[C@@H](CC1=CC=NC2=CC=C(N=C12)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O GZFLUMCQCQYJQR-NEWSRXKRSA-N 0.000 claims description 2
- LYXTWSVOAFQIIP-NEWSRXKRSA-N O[C@@H](CC1=CC=NC2=CC=C(N=C12)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@@H](CC1=CC=NC2=CC=C(N=C12)OC)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O LYXTWSVOAFQIIP-NEWSRXKRSA-N 0.000 claims description 2
- NBVFLYCKGZUYNY-OQUCYHQFSA-N O[C@@H]([C@H](C1=C2N=C(C=NC2=CC=C1)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@@H]([C@H](C1=C2N=C(C=NC2=CC=C1)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O NBVFLYCKGZUYNY-OQUCYHQFSA-N 0.000 claims description 2
- GUEBWQFTJDQZMH-OQUCYHQFSA-N O[C@@H]([C@H](C1=CC=NC2=CC=C(N=C12)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@@H]([C@H](C1=CC=NC2=CC=C(N=C12)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O GUEBWQFTJDQZMH-OQUCYHQFSA-N 0.000 claims description 2
- QYTDPYXBNNFTCH-LLQVLPNTSA-N O[C@@H]([C@H](C1=CC=NC2=CC=C(N=C12)OC)O)[C@H]1CC[C@@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O Chemical compound O[C@@H]([C@H](C1=CC=NC2=CC=C(N=C12)OC)O)[C@H]1CC[C@@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O QYTDPYXBNNFTCH-LLQVLPNTSA-N 0.000 claims description 2
- BCJXHIWTCHGWSA-RECSWBGYSA-N O[C@@H]1[C@H](CO[C@@H]([C@@H]1O)COC1=CC=NC2=CC=C(C=C12)OC)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@@H]1[C@H](CO[C@@H]([C@@H]1O)COC1=CC=NC2=CC=C(C=C12)OC)NCC=1C=CC=2SCC(NC2N1)=O BCJXHIWTCHGWSA-RECSWBGYSA-N 0.000 claims description 2
- GZFLUMCQCQYJQR-QXAKKESOSA-N O[C@H](CC1=CC=NC2=CC=C(N=C12)OC)[C@H]1CC[C@@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O Chemical compound O[C@H](CC1=CC=NC2=CC=C(N=C12)OC)[C@H]1CC[C@@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O GZFLUMCQCQYJQR-QXAKKESOSA-N 0.000 claims description 2
- XQDGBWSKWGOWMB-HYFFOGBASA-N O[C@H](C[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)C1=C2C=C(C=NC2=CC=C1)OC Chemical compound O[C@H](C[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)C1=C2C=C(C=NC2=CC=C1)OC XQDGBWSKWGOWMB-HYFFOGBASA-N 0.000 claims description 2
- XDSNXCUNLPVVCD-XPORGRDOSA-N O[C@H]([C@@H](C1=C2C=C(C=NC2=CC=C1)OC)O)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@H]([C@@H](C1=C2C=C(C=NC2=CC=C1)OC)O)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O XDSNXCUNLPVVCD-XPORGRDOSA-N 0.000 claims description 2
- DAASMUXJHJWYQB-PJFJWIBOSA-N O[C@H]([C@@H](C1=C2N=C(C=NC2=CC=C1)OC)O)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@H]([C@@H](C1=C2N=C(C=NC2=CC=C1)OC)O)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O DAASMUXJHJWYQB-PJFJWIBOSA-N 0.000 claims description 2
- PUGKCJDNKFNQRC-HRULMYSOSA-N O[C@H]([C@@H](C1=C2N=C(C=NC2=CC=C1)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O Chemical compound O[C@H]([C@@H](C1=C2N=C(C=NC2=CC=C1)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O PUGKCJDNKFNQRC-HRULMYSOSA-N 0.000 claims description 2
- NBVFLYCKGZUYNY-HRULMYSOSA-N O[C@H]([C@@H](C1=C2N=C(C=NC2=CC=C1)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@H]([C@@H](C1=C2N=C(C=NC2=CC=C1)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O NBVFLYCKGZUYNY-HRULMYSOSA-N 0.000 claims description 2
- NBVFLYCKGZUYNY-ICNVXMQJSA-N O[C@H]([C@@H](C1=C2N=C(C=NC2=CC=C1)OC)O)[C@H]1CC[C@@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound O[C@H]([C@@H](C1=C2N=C(C=NC2=CC=C1)OC)O)[C@H]1CC[C@@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O NBVFLYCKGZUYNY-ICNVXMQJSA-N 0.000 claims description 2
- QYTDPYXBNNFTCH-ICNVXMQJSA-N O[C@H]([C@@H](C1=CC=NC2=CC=C(N=C12)OC)O)[C@H]1CC[C@@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O Chemical compound O[C@H]([C@@H](C1=CC=NC2=CC=C(N=C12)OC)O)[C@H]1CC[C@@H](CO1)NCC=1C=CC=2OCC(NC2N1)=O QYTDPYXBNNFTCH-ICNVXMQJSA-N 0.000 claims description 2
- 102100022122 Ras-related C3 botulinum toxin substrate 1 Human genes 0.000 claims description 2
- MDGVUAMHFUFMCU-UHFFFAOYSA-N n-(2-cyanoquinolin-8-yl)-3-[1-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)piperidin-3-yl]propanamide Chemical compound C1=C(C#N)N=C2C(NC(CCC3CN(CC=4C=C5OCCOC5=CC=4)CCC3)=O)=CC=CC2=C1 MDGVUAMHFUFMCU-UHFFFAOYSA-N 0.000 claims description 2
- HQFMACQBSSJWSX-UHFFFAOYSA-N n-(6-methoxy-1,5-naphthyridin-4-yl)-3-[1-(2-thiophen-2-ylsulfanylethyl)piperidin-3-yl]propanamide Chemical compound C12=NC(OC)=CC=C2N=CC=C1NC(=O)CCC(C1)CCCN1CCSC1=CC=CS1 HQFMACQBSSJWSX-UHFFFAOYSA-N 0.000 claims description 2
- JTGPZYMRAGZRIF-UHFFFAOYSA-N n-(6-methoxy-1,5-naphthyridin-4-yl)-3-[1-[(3-oxo-4h-1,4-benzoxazin-6-yl)methyl]piperidin-3-yl]propanamide Chemical compound O1CC(=O)NC2=CC(CN3CCCC(C3)CCC(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 JTGPZYMRAGZRIF-UHFFFAOYSA-N 0.000 claims description 2
- IZECKVWXXYSQQH-UHFFFAOYSA-N n-(6-methoxy-1,5-naphthyridin-4-yl)-3-[[(3-oxo-4h-pyrido[3,2-b][1,4]oxazin-6-yl)methylamino]methyl]cyclohexane-1-carboxamide Chemical compound O1CC(=O)NC2=NC(CNCC3CCCC(C3)C(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 IZECKVWXXYSQQH-UHFFFAOYSA-N 0.000 claims description 2
- IBMLXGUWHJXRFN-UHFFFAOYSA-N n-[(3,4-dichlorophenyl)methyl]-6-[2-(8-fluoro-6-methoxyquinolin-4-yl)ethyl]oxan-3-amine Chemical compound C12=CC(OC)=CC(F)=C2N=CC=C1CCC(OC1)CCC1NCC1=CC=C(Cl)C(Cl)=C1 IBMLXGUWHJXRFN-UHFFFAOYSA-N 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- XLPZVGBRDWRGRG-MJGOQNOKSA-N (2s,5r)-n-(2-cyanoquinolin-8-yl)-5-[(3-oxo-4h-pyrido[3,2-b][1,4]thiazin-6-yl)methylamino]oxane-2-carboxamide Chemical compound S1CC(=O)NC2=NC(CN[C@@H]3CC[C@H](OC3)C(NC=3C4=NC(=CC=C4C=CC=3)C#N)=O)=CC=C21 XLPZVGBRDWRGRG-MJGOQNOKSA-N 0.000 claims 1
- AJRAAAKFLIDMJB-MOPGFXCFSA-N (3r,6s)-n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-6-[(3-methoxyquinolin-5-yl)oxymethyl]oxan-3-amine Chemical compound O1CCOC2=CC(CN[C@@H]3CC[C@H](OC3)COC3=CC=CC4=NC=C(C=C43)OC)=CC=C21 AJRAAAKFLIDMJB-MOPGFXCFSA-N 0.000 claims 1
- ZIEKVRDXDUZMKV-QZTJIDSGSA-N 6-[[[(3r,6r)-6-[2-(6-methoxy-1,5-naphthyridin-4-yl)ethyl]oxan-3-yl]amino]methyl]-4h-pyrido[3,2-b][1,4]thiazin-3-one Chemical compound S1CC(=O)NC2=NC(CN[C@@H]3CC[C@H](OC3)CCC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 ZIEKVRDXDUZMKV-QZTJIDSGSA-N 0.000 claims 1
- UZDPVYWWUHAFSS-MSOLQXFVSA-N 6-[[[(3r,6s)-6-[(3-methoxyquinolin-5-yl)oxymethyl]oxan-3-yl]amino]methyl]-4h-1,4-benzoxazin-3-one Chemical compound O1CC(=O)NC2=CC(CN[C@@H]3CC[C@H](OC3)COC3=CC=CC4=NC=C(C=C43)OC)=CC=C21 UZDPVYWWUHAFSS-MSOLQXFVSA-N 0.000 claims 1
- VVICNROVRMVIAW-IEAUQHRDSA-N 6-[[[(3r,6s)-6-[2-hydroxy-2-(6-methoxy-1,5-naphthyridin-4-yl)ethyl]oxan-3-yl]amino]methyl]-4h-pyrido[3,2-b][1,4]thiazin-3-one Chemical compound S1CC(=O)NC2=NC(CN[C@@H]3CC[C@H](OC3)CC(O)C3=CC=NC4=CC=C(N=C43)OC)=CC=C21 VVICNROVRMVIAW-IEAUQHRDSA-N 0.000 claims 1
- RZIZBNFEJOMCBL-SJORKVTESA-N 7-fluoro-6-[[[(3r,6s)-6-[(3-methoxyquinolin-5-yl)oxymethyl]oxan-3-yl]amino]methyl]-4h-1,4-benzothiazin-3-one Chemical compound N1C(=O)CSC(C=C2F)=C1C=C2CN[C@@H](CO1)CC[C@H]1COC1=CC=CC2=NC=C(OC)C=C21 RZIZBNFEJOMCBL-SJORKVTESA-N 0.000 claims 1
- UNYYLFTVDOLTDN-OZEDYNDGSA-N C(#N)C1=NC2=C(C=CC=C2C=C1)[C@H]([C@@H](O)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O)O Chemical compound C(#N)C1=NC2=C(C=CC=C2C=C1)[C@H]([C@@H](O)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O)O UNYYLFTVDOLTDN-OZEDYNDGSA-N 0.000 claims 1
- DWDUILAZGBQKPE-WOJBJXKFSA-N COC=1C=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CS2)=O)C1 Chemical compound COC=1C=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CS2)=O)C1 DWDUILAZGBQKPE-WOJBJXKFSA-N 0.000 claims 1
- IDJZIYASVCPJQW-DLBZAZTESA-N COC=1C=C2C(=NC=NC2=CC1)OC[C@@H]1N(C[C@H](CC1)NCC=1C=CC=2SCC(NC2N1)=O)CC(=O)O Chemical compound COC=1C=C2C(=NC=NC2=CC1)OC[C@@H]1N(C[C@H](CC1)NCC=1C=CC=2SCC(NC2N1)=O)CC(=O)O IDJZIYASVCPJQW-DLBZAZTESA-N 0.000 claims 1
- BFKGGMMEDVQSKI-MAUKXSAKSA-N COC=1N=C2C(=CC=NC2=CC1)NC(=O)[C@@H]1NC[C@H](CC1)NCC=1C=CC2=C(NC(CS2)=O)C1 Chemical compound COC=1N=C2C(=CC=NC2=CC1)NC(=O)[C@@H]1NC[C@H](CC1)NCC=1C=CC2=C(NC(CS2)=O)C1 BFKGGMMEDVQSKI-MAUKXSAKSA-N 0.000 claims 1
- FOPOYPYIACIRIB-WBVHZDCISA-N FC(OC=1C=C2C(=CC=NC2=CC1)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)(F)F Chemical compound FC(OC=1C=C2C(=CC=NC2=CC1)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)(F)F FOPOYPYIACIRIB-WBVHZDCISA-N 0.000 claims 1
- IJLVUABMRWRZJZ-BBTOPDLWSA-N FC1=C(C=C(C=C1)F)/C=C/C(=O)N[C@H]1CO[C@@H](CC1)CC(C1=CC=NC2=CC=C(N=C12)OC)O Chemical compound FC1=C(C=C(C=C1)F)/C=C/C(=O)N[C@H]1CO[C@@H](CC1)CC(C1=CC=NC2=CC=C(N=C12)OC)O IJLVUABMRWRZJZ-BBTOPDLWSA-N 0.000 claims 1
- CKGPUJFMMCSATJ-PBBMUBKISA-N FC1=C(C=C(C=C1)F)/C=C/C(=O)N[C@H]1CO[C@@H](CC1)[C@H](CC1=CC=NC2=CC=C(C=C12)OC)O Chemical compound FC1=C(C=C(C=C1)F)/C=C/C(=O)N[C@H]1CO[C@@H](CC1)[C@H](CC1=CC=NC2=CC=C(C=C12)OC)O CKGPUJFMMCSATJ-PBBMUBKISA-N 0.000 claims 1
- DBJQMKHDOQWLKG-JBAJJWIUSA-N FC1=C(C=C(C=C1)F)/C=C/C(=O)N[C@H]1[C@H](O[C@@H](CC1)CCC1=CC=NC2=CC=C(N=C12)OC)CCO Chemical compound FC1=C(C=C(C=C1)F)/C=C/C(=O)N[C@H]1[C@H](O[C@@H](CC1)CCC1=CC=NC2=CC=C(N=C12)OC)CCO DBJQMKHDOQWLKG-JBAJJWIUSA-N 0.000 claims 1
- JWNNNCVQCHRKTN-CZAAIQMYSA-N FC=1C=C(C=C2C(=CC=NC12)C[C@H](O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)OC Chemical compound FC=1C=C(C=C2C(=CC=NC12)C[C@H](O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)OC JWNNNCVQCHRKTN-CZAAIQMYSA-N 0.000 claims 1
- WUQJSSZDEKOWSM-CVEARBPZSA-N FC=1C=C(C=C2C(=CC=NC12)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)OC Chemical compound FC=1C=C(C=C2C(=CC=NC12)OC[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)OC WUQJSSZDEKOWSM-CVEARBPZSA-N 0.000 claims 1
- OCZXFLPYVJPVBO-SGLUODAXSA-N FC=1C=C(C=C2C(=CC=NC12)[C@H]([C@@H](O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)O)OC Chemical compound FC=1C=C(C=C2C(=CC=NC12)[C@H]([C@@H](O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)O)OC OCZXFLPYVJPVBO-SGLUODAXSA-N 0.000 claims 1
- LLQPQVKOKNNJSR-KUDFPVQQSA-N FC=1C=NC2=CC=C(C=C2C1[C@H](C[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)O)OC Chemical compound FC=1C=NC2=CC=C(C=C2C1[C@H](C[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O)O)OC LLQPQVKOKNNJSR-KUDFPVQQSA-N 0.000 claims 1
- AJTOYYUJDRUSMT-HTZLEHNLSA-N FC=1C=NC2=CC=C(N=C2C1[C@H]([C@H](O)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O)O)OC Chemical compound FC=1C=NC2=CC=C(N=C2C1[C@H]([C@H](O)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2SCC(NC2N1)=O)O)OC AJTOYYUJDRUSMT-HTZLEHNLSA-N 0.000 claims 1
- VTGBDYOYPUTOFG-CVEARBPZSA-N Fc1cc(F)c2nccc(OC[C@@H]3CC[C@H](CO3)NCc3ccc4SCC(=O)Nc4n3)c2c1 Chemical compound Fc1cc(F)c2nccc(OC[C@@H]3CC[C@H](CO3)NCc3ccc4SCC(=O)Nc4n3)c2c1 VTGBDYOYPUTOFG-CVEARBPZSA-N 0.000 claims 1
- MEKREBAGWDQWIU-NQERJWCQSA-N O[C@@H](CC1=C2C=C(C=NC2=CC=C1)OC)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2OCC(NC2N1)=O Chemical compound O[C@@H](CC1=C2C=C(C=NC2=CC=C1)OC)[C@@H]1CC[C@H](CO1)NC(=O)C=1C=CC=2OCC(NC2N1)=O MEKREBAGWDQWIU-NQERJWCQSA-N 0.000 claims 1
- BTWQMHQCJBRYSE-CTNGQTDRSA-N n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-1-[(1r,3s)-3-[(6-methoxyquinolin-4-yl)oxymethyl]cyclohexyl]methanamine Chemical compound O1CCOC2=CC(CNC[C@@H]3CCC[C@@H](C3)COC3=CC=NC4=CC=C(C=C43)OC)=CC=C21 BTWQMHQCJBRYSE-CTNGQTDRSA-N 0.000 claims 1
- PPGWXHXPYWBXSZ-UHFFFAOYSA-N n-(2-cyanoquinolin-8-yl)-3-[1-[(3-oxo-4h-1,4-benzothiazin-6-yl)methyl]piperidin-3-yl]propanamide Chemical compound C1=C(C#N)N=C2C(NC(CCC3CN(CC=4C=C5NC(=O)CSC5=CC=4)CCC3)=O)=CC=CC2=C1 PPGWXHXPYWBXSZ-UHFFFAOYSA-N 0.000 claims 1
- XUXDDUJAACRVKW-UHFFFAOYSA-N n-(6-methoxy-1,5-naphthyridin-4-yl)-3-[1-[(3-oxo-4h-pyrido[3,2-b][1,4]thiazin-6-yl)methyl]piperidin-3-yl]propanamide Chemical compound S1CC(=O)NC2=NC(CN3CCCC(C3)CCC(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 XUXDDUJAACRVKW-UHFFFAOYSA-N 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 abstract description 16
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 description 388
- 238000000034 method Methods 0.000 description 256
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 218
- 239000007787 solid Substances 0.000 description 212
- 239000000243 solution Substances 0.000 description 204
- 239000006260 foam Substances 0.000 description 132
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 115
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 111
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 106
- 239000000741 silica gel Substances 0.000 description 104
- 229910002027 silica gel Inorganic materials 0.000 description 104
- 239000011541 reaction mixture Substances 0.000 description 101
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 99
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 98
- 101150041968 CDC13 gene Proteins 0.000 description 97
- 238000005481 NMR spectroscopy Methods 0.000 description 94
- 238000006243 chemical reaction Methods 0.000 description 94
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 93
- 235000013350 formula milk Nutrition 0.000 description 90
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 77
- YMWUJEATGCHHMB-UHFFFAOYSA-N dichloromethane Natural products ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 75
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 71
- 239000003921 oil Substances 0.000 description 71
- 235000019198 oils Nutrition 0.000 description 71
- 239000010410 layer Substances 0.000 description 70
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 69
- 239000012044 organic layer Substances 0.000 description 68
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 65
- 235000011114 ammonium hydroxide Nutrition 0.000 description 65
- 230000002829 reductive effect Effects 0.000 description 65
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 60
- 239000012267 brine Substances 0.000 description 59
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 59
- 238000005160 1H NMR spectroscopy Methods 0.000 description 58
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 53
- 239000007832 Na2SO4 Substances 0.000 description 51
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 51
- 229910052938 sodium sulfate Inorganic materials 0.000 description 51
- 235000011152 sodium sulphate Nutrition 0.000 description 51
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 50
- 238000004587 chromatography analysis Methods 0.000 description 49
- 239000003039 volatile agent Substances 0.000 description 47
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 44
- 150000001412 amines Chemical class 0.000 description 43
- 239000000706 filtrate Substances 0.000 description 43
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 42
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 42
- 229960004756 ethanol Drugs 0.000 description 42
- 125000006850 spacer group Chemical group 0.000 description 39
- VEPGNAIYGRUSIA-UHFFFAOYSA-N 3-oxo-4h-pyrido[3,2-b][1,4]thiazine-6-carbaldehyde Chemical compound S1CC(=O)NC2=NC(C=O)=CC=C21 VEPGNAIYGRUSIA-UHFFFAOYSA-N 0.000 description 35
- 239000000284 extract Substances 0.000 description 34
- 238000001914 filtration Methods 0.000 description 34
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 31
- 235000019341 magnesium sulphate Nutrition 0.000 description 30
- 239000012279 sodium borohydride Substances 0.000 description 30
- 229910000033 sodium borohydride Inorganic materials 0.000 description 30
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 30
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 29
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 27
- CWKXDPPQCVWXAG-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodioxine-6-carbaldehyde Chemical compound O1CCOC2=CC(C=O)=CC=C21 CWKXDPPQCVWXAG-UHFFFAOYSA-N 0.000 description 26
- 238000003756 stirring Methods 0.000 description 24
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 23
- 238000001816 cooling Methods 0.000 description 23
- 235000017557 sodium bicarbonate Nutrition 0.000 description 22
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 22
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 21
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 19
- 150000001299 aldehydes Chemical class 0.000 description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 125000004432 carbon atom Chemical group C* 0.000 description 17
- 238000004440 column chromatography Methods 0.000 description 17
- 150000003254 radicals Chemical class 0.000 description 17
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 15
- 239000002253 acid Substances 0.000 description 15
- GBOGHJYGGDERQX-UHFFFAOYSA-N 3-oxo-4h-1,4-benzothiazine-6-carbaldehyde Chemical compound S1CC(=O)NC2=CC(C=O)=CC=C21 GBOGHJYGGDERQX-UHFFFAOYSA-N 0.000 description 14
- GAGAICHLGQDUTL-UHFFFAOYSA-N 4h-thiazin-3-one Chemical compound O=C1CC=CSN1 GAGAICHLGQDUTL-UHFFFAOYSA-N 0.000 description 14
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 14
- 239000002808 molecular sieve Substances 0.000 description 14
- 229910000027 potassium carbonate Inorganic materials 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 125000006239 protecting group Chemical group 0.000 description 14
- 229920006395 saturated elastomer Polymers 0.000 description 14
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 14
- 239000012298 atmosphere Substances 0.000 description 13
- 238000001035 drying Methods 0.000 description 13
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 13
- XOXXGNIBXYQQNS-UHFFFAOYSA-N 3-oxo-4h-pyrido[3,2-b][1,4]oxazine-6-carbaldehyde Chemical compound O1CC(=O)NC2=NC(C=O)=CC=C21 XOXXGNIBXYQQNS-UHFFFAOYSA-N 0.000 description 12
- UIRSLBDCOYTZPH-UHFFFAOYSA-N 4h-1,4-thiazin-3-one Chemical compound O=C1CSC=CN1 UIRSLBDCOYTZPH-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 12
- 150000002009 diols Chemical class 0.000 description 12
- 238000001704 evaporation Methods 0.000 description 12
- 230000008020 evaporation Effects 0.000 description 12
- 239000007821 HATU Substances 0.000 description 11
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 11
- 150000001345 alkine derivatives Chemical class 0.000 description 11
- 150000001408 amides Chemical class 0.000 description 11
- 229910052731 fluorine Inorganic materials 0.000 description 11
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 11
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 11
- 125000001424 substituent group Chemical group 0.000 description 11
- 239000000725 suspension Substances 0.000 description 11
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 11
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 239000000460 chlorine Substances 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 10
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 9
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 9
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 9
- 229910017974 NH40H Inorganic materials 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000000010 aprotic solvent Substances 0.000 description 9
- 239000003054 catalyst Substances 0.000 description 9
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 8
- CSUZMBGLKCRFKF-UHFFFAOYSA-N 2h-thiazine-6-carbaldehyde Chemical compound O=CC1=CC=CNS1 CSUZMBGLKCRFKF-UHFFFAOYSA-N 0.000 description 8
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 8
- RVTLXJLNIDCHKT-UHFFFAOYSA-N 6-methoxy-1h-quinolin-4-one Chemical compound N1=CC=C(O)C2=CC(OC)=CC=C21 RVTLXJLNIDCHKT-UHFFFAOYSA-N 0.000 description 8
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 8
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- 229910052801 chlorine Inorganic materials 0.000 description 8
- 238000005859 coupling reaction Methods 0.000 description 8
- 150000002118 epoxides Chemical class 0.000 description 8
- 239000011737 fluorine Substances 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 150000007530 organic bases Chemical class 0.000 description 8
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- RQCNHUCCQJMSRG-UHFFFAOYSA-N tert-butyl piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCCC1 RQCNHUCCQJMSRG-UHFFFAOYSA-N 0.000 description 8
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 8
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 7
- 150000001336 alkenes Chemical class 0.000 description 7
- 230000003197 catalytic effect Effects 0.000 description 7
- 125000000753 cycloalkyl group Chemical group 0.000 description 7
- 230000003292 diminished effect Effects 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 6
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 6
- SUDWZZCLUSUTBF-UHFFFAOYSA-N 2,3-dihydro-[1,4]dioxino[2,3-b]pyridine-6-carbaldehyde Chemical compound O1CCOC2=NC(C=O)=CC=C21 SUDWZZCLUSUTBF-UHFFFAOYSA-N 0.000 description 6
- VHKABBARGFUYOF-UHFFFAOYSA-N 3-oxo-4h-1,4-benzoxazine-6-carbaldehyde Chemical compound O1CC(=O)NC2=CC(C=O)=CC=C21 VHKABBARGFUYOF-UHFFFAOYSA-N 0.000 description 6
- DYHSDKLCOJIUFX-UHFFFAOYSA-N Di-tert-butyl dicarbonate Substances CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 6
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 6
- 229910052794 bromium Inorganic materials 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 6
- NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical compound C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 description 6
- 125000005842 heteroatom Chemical group 0.000 description 6
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 125000002827 triflate group Chemical group FC(S(=O)(=O)O*)(F)F 0.000 description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 6
- GGKJSDIZPPMNGO-UHFFFAOYSA-N (2-cyanoquinolin-8-yl) trifluoromethanesulfonate Chemical compound C1=C(C#N)N=C2C(OS(=O)(=O)C(F)(F)F)=CC=CC2=C1 GGKJSDIZPPMNGO-UHFFFAOYSA-N 0.000 description 5
- OMWBUWDHEZIMGQ-UHFFFAOYSA-N 2,3-dihydro-[1,4]dioxino[2,3-c]pyridine-7-carbaldehyde Chemical compound O1CCOC2=C1C=C(C=O)N=C2 OMWBUWDHEZIMGQ-UHFFFAOYSA-N 0.000 description 5
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 5
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 5
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 5
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 5
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 5
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- 150000005054 naphthyridines Chemical class 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 5
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 5
- 238000000844 transformation Methods 0.000 description 5
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 5
- PPZNNZQHBXZAPS-UHFFFAOYSA-N (6-methoxy-1,5-naphthyridin-4-yl) trifluoromethanesulfonate Chemical compound N1=CC=C(OS(=O)(=O)C(F)(F)F)C2=NC(OC)=CC=C21 PPZNNZQHBXZAPS-UHFFFAOYSA-N 0.000 description 4
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 4
- ADDZHRRCUWNSCS-UHFFFAOYSA-N 2-Benzofurancarboxaldehyde Chemical compound C1=CC=C2OC(C=O)=CC2=C1 ADDZHRRCUWNSCS-UHFFFAOYSA-N 0.000 description 4
- AWEZTTWEBOCJAV-UHFFFAOYSA-N 3-methoxyquinolin-5-ol Chemical compound C1=CC=C(O)C2=CC(OC)=CN=C21 AWEZTTWEBOCJAV-UHFFFAOYSA-N 0.000 description 4
- HOPFINDBXLGBEL-UHFFFAOYSA-N 3-methoxyquinoline-5-carbaldehyde Chemical compound C1=CC=C(C=O)C2=CC(OC)=CN=C21 HOPFINDBXLGBEL-UHFFFAOYSA-N 0.000 description 4
- BIGSOYZPKXOBJZ-UHFFFAOYSA-N 4-chloro-8-methoxyquinazoline Chemical compound N1=CN=C2C(OC)=CC=CC2=C1Cl BIGSOYZPKXOBJZ-UHFFFAOYSA-N 0.000 description 4
- JVVRCYWZTJLJSG-UHFFFAOYSA-N 4-dimethylaminophenol Chemical compound CN(C)C1=CC=C(O)C=C1 JVVRCYWZTJLJSG-UHFFFAOYSA-N 0.000 description 4
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-dimethylaminopyridine Substances CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- FEJUGLKDZJDVFY-UHFFFAOYSA-N 9-borabicyclo(3.3.1)nonane Chemical compound C1CCC2CCCC1B2 FEJUGLKDZJDVFY-UHFFFAOYSA-N 0.000 description 4
- 101001053401 Arabidopsis thaliana Acid beta-fructofuranosidase 3, vacuolar Proteins 0.000 description 4
- 101100132433 Arabidopsis thaliana VIII-1 gene Proteins 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 241000193996 Streptococcus pyogenes Species 0.000 description 4
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 4
- 241000534944 Thia Species 0.000 description 4
- SORGEQQSQGNZFI-UHFFFAOYSA-N [azido(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(N=[N+]=[N-])OC1=CC=CC=C1 SORGEQQSQGNZFI-UHFFFAOYSA-N 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 125000005605 benzo group Chemical group 0.000 description 4
- 125000004532 benzofuran-3-yl group Chemical group O1C=C(C2=C1C=CC=C2)* 0.000 description 4
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 4
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 4
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 229910052763 palladium Inorganic materials 0.000 description 4
- 150000002940 palladium Chemical class 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 150000003457 sulfones Chemical class 0.000 description 4
- 235000011149 sulphuric acid Nutrition 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- 229940086542 triethylamine Drugs 0.000 description 4
- ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- ZDAGAXAGFIRGGV-NTSWFWBYSA-N (2r,5s)-5-methoxycarbonylpiperidine-2-carboxylic acid Chemical compound COC(=O)[C@H]1CC[C@H](C(O)=O)NC1 ZDAGAXAGFIRGGV-NTSWFWBYSA-N 0.000 description 3
- YUCBLVFHJWOYDN-HVLQGHBFSA-N 1,4-bis[(s)-[(2r,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methoxy]phthalazine Chemical compound C1=C(OC)C=C2C([C@H](OC=3C4=CC=CC=C4C(O[C@H]([C@@H]4N5CC[C@H]([C@H](C5)CC)C4)C=4C5=CC(OC)=CC=C5N=CC=4)=NN=3)[C@H]3C[C@@H]4CCN3C[C@@H]4CC)=CC=NC2=C1 YUCBLVFHJWOYDN-HVLQGHBFSA-N 0.000 description 3
- GGZHVNZHFYCSEV-UHFFFAOYSA-N 1-Phenyl-5-mercaptotetrazole Chemical compound SC1=NN=NN1C1=CC=CC=C1 GGZHVNZHFYCSEV-UHFFFAOYSA-N 0.000 description 3
- ILEYSCVQRULQKW-UHFFFAOYSA-N 2-chloro-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethanone Chemical compound O1CCOC2=CC(C(=O)CCl)=CC=C21 ILEYSCVQRULQKW-UHFFFAOYSA-N 0.000 description 3
- 150000004331 4-hydroxyquinolines Chemical class 0.000 description 3
- XISPDFMAOWZEQG-UHFFFAOYSA-N 4h-1,4-oxazin-3-one Chemical compound O=C1COC=CN1 XISPDFMAOWZEQG-UHFFFAOYSA-N 0.000 description 3
- YNVIAXULFXXTLV-UHFFFAOYSA-N 5-bromo-3-methoxyquinoline Chemical compound C1=CC=C(Br)C2=CC(OC)=CN=C21 YNVIAXULFXXTLV-UHFFFAOYSA-N 0.000 description 3
- SSMACLPPRSQXHH-UHFFFAOYSA-N 6-methoxy-1h-1,5-naphthyridin-4-one Chemical compound N1C=CC(=O)C2=NC(OC)=CC=C21 SSMACLPPRSQXHH-UHFFFAOYSA-N 0.000 description 3
- 101100459319 Arabidopsis thaliana VIII-2 gene Proteins 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- 241000606768 Haemophilus influenzae Species 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 108010059993 Vancomycin Proteins 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 150000001502 aryl halides Chemical class 0.000 description 3
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 3
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 3
- 229910000085 borane Inorganic materials 0.000 description 3
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 3
- 229910000024 caesium carbonate Inorganic materials 0.000 description 3
- 229910052681 coesite Inorganic materials 0.000 description 3
- 229910052906 cristobalite Inorganic materials 0.000 description 3
- 150000005676 cyclic carbonates Chemical class 0.000 description 3
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- GUVUOGQBMYCBQP-UHFFFAOYSA-N dmpu Chemical compound CN1CCCN(C)C1=O GUVUOGQBMYCBQP-UHFFFAOYSA-N 0.000 description 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- 150000007529 inorganic bases Chemical class 0.000 description 3
- UEXQBEVWFZKHNB-UHFFFAOYSA-N intermediate 29 Natural products C1=CC(N)=CC=C1NC1=NC=CC=N1 UEXQBEVWFZKHNB-UHFFFAOYSA-N 0.000 description 3
- MHCFAGZWMAWTNR-UHFFFAOYSA-M lithium perchlorate Chemical compound [Li+].[O-]Cl(=O)(=O)=O MHCFAGZWMAWTNR-UHFFFAOYSA-M 0.000 description 3
- 229910001486 lithium perchlorate Inorganic materials 0.000 description 3
- 125000001624 naphthyl group Chemical group 0.000 description 3
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 229910052682 stishovite Inorganic materials 0.000 description 3
- 229910052905 tridymite Inorganic materials 0.000 description 3
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 3
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 3
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 3
- VFJYIHQDILEQNR-UHFFFAOYSA-M trimethylsulfanium;iodide Chemical compound [I-].C[S+](C)C VFJYIHQDILEQNR-UHFFFAOYSA-M 0.000 description 3
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 3
- 229960003165 vancomycin Drugs 0.000 description 3
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 2
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 2
- NROSRTMHTJHLLE-SFYZADRCSA-N (2s,5r)-5-[(2-methylpropan-2-yl)oxycarbonylamino]oxane-2-carboxylic acid Chemical compound CC(C)(C)OC(=O)N[C@@H]1CC[C@@H](C(O)=O)OC1 NROSRTMHTJHLLE-SFYZADRCSA-N 0.000 description 2
- IPZFSKQTSOMKSJ-UHNVWZDZSA-N (2s,5r)-5-aminooxane-2-carboxylic acid Chemical compound N[C@@H]1CC[C@@H](C(O)=O)OC1 IPZFSKQTSOMKSJ-UHNVWZDZSA-N 0.000 description 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 2
- LJOQGZACKSYWCH-LHHVKLHASA-N (s)-[(2r,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol Chemical compound C1=C(OC)C=C2C([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4CC)=CC=NC2=C1 LJOQGZACKSYWCH-LHHVKLHASA-N 0.000 description 2
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 description 2
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 2
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 2
- NXILIHONWRXHFA-UHFFFAOYSA-N 1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-3-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1CCCC(C(O)=O)C1 NXILIHONWRXHFA-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- QMNUDYFKZYBWQX-UHFFFAOYSA-N 1H-quinazolin-4-one Chemical compound C1=CC=C2C(=O)N=CNC2=C1 QMNUDYFKZYBWQX-UHFFFAOYSA-N 0.000 description 2
- NSPLFNGUPLZYHV-UHFFFAOYSA-N 1h-1,5-naphthyridin-4-one Chemical class C1=CN=C2C(O)=CC=NC2=C1 NSPLFNGUPLZYHV-UHFFFAOYSA-N 0.000 description 2
- GEFIFDVQYCPLHC-UHFFFAOYSA-N 2,1,3-benzothiadiazole-5-carbaldehyde Chemical compound C1=C(C=O)C=CC2=NSN=C21 GEFIFDVQYCPLHC-UHFFFAOYSA-N 0.000 description 2
- XXMFJKNOJSDQBM-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;hydrate Chemical compound [OH3+].[O-]C(=O)C(F)(F)F XXMFJKNOJSDQBM-UHFFFAOYSA-N 0.000 description 2
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 2
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 2
- FWZVLBHXKUTGNV-UHFFFAOYSA-N 2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCCC1=CC=C(OCCO2)C2=C1 FWZVLBHXKUTGNV-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- DRLPWCAENQZXJT-UHFFFAOYSA-N 2-[(dimethylazaniumyl)amino]acetate Chemical compound CN(C)NCC(O)=O DRLPWCAENQZXJT-UHFFFAOYSA-N 0.000 description 2
- AACUYXPCLUSFMI-UHFFFAOYSA-N 2-bromo-n-(1,3-thiazol-2-yl)acetamide Chemical compound BrCC(=O)NC1=NC=CS1 AACUYXPCLUSFMI-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N 2-propanol Substances CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- QFZTUWOWMRNMAH-UHFFFAOYSA-N 2h-pyran-2-carboxylic acid Chemical compound OC(=O)C1OC=CC=C1 QFZTUWOWMRNMAH-UHFFFAOYSA-N 0.000 description 2
- IBADFXOMCWHDMS-UHFFFAOYSA-N 3,5-dibromoquinoline Chemical compound C1=CC=C(Br)C2=CC(Br)=CN=C21 IBADFXOMCWHDMS-UHFFFAOYSA-N 0.000 description 2
- ZJOJOFQKUQQERL-UHFFFAOYSA-N 3-[(2,3-dihydro-1,4-benzodioxin-6-ylmethylamino)methyl]cyclohexane-1-carboxylic acid Chemical compound C1C(C(=O)O)CCCC1CNCC1=CC=C(OCCO2)C2=C1 ZJOJOFQKUQQERL-UHFFFAOYSA-N 0.000 description 2
- ZVYVZEUADCRFHK-UHFFFAOYSA-N 3-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]propanoic acid Chemical compound CC(C)(C)OC(=O)N1CCCC(CCC(O)=O)C1 ZVYVZEUADCRFHK-UHFFFAOYSA-N 0.000 description 2
- MREJJMASIQVOTH-UHFFFAOYSA-N 4-chloro-6-methoxyquinazoline Chemical compound N1=CN=C(Cl)C2=CC(OC)=CC=C21 MREJJMASIQVOTH-UHFFFAOYSA-N 0.000 description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 2
- ZRQABNJYWSVSCU-UHFFFAOYSA-N 4-oxo-1h-quinoline-6-carbonitrile Chemical compound C1=C(C#N)C=C2C(O)=CC=NC2=C1 ZRQABNJYWSVSCU-UHFFFAOYSA-N 0.000 description 2
- 125000004863 4-trifluoromethoxyphenyl group Chemical group [H]C1=C([H])C(OC(F)(F)F)=C([H])C([H])=C1* 0.000 description 2
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 2
- GVUSWMIMPJDWNW-UHFFFAOYSA-N 4h-pyrido[3,2-b][1,4]thiazin-3-one Chemical compound C1=CN=C2NC(=O)CSC2=C1 GVUSWMIMPJDWNW-UHFFFAOYSA-N 0.000 description 2
- JSHPICHDBDUEFJ-UHFFFAOYSA-N 6-methoxy-1,5-naphthyridine-4-carbaldehyde Chemical compound N1=CC=C(C=O)C2=NC(OC)=CC=C21 JSHPICHDBDUEFJ-UHFFFAOYSA-N 0.000 description 2
- MBVGYFIYXWVPQY-UHFFFAOYSA-N 6-methoxy-4-methylquinoline Chemical compound N1=CC=C(C)C2=CC(OC)=CC=C21 MBVGYFIYXWVPQY-UHFFFAOYSA-N 0.000 description 2
- PDGKZDPIWAKVLH-UHFFFAOYSA-N 6-methoxyquinoline-4-carbaldehyde Chemical compound N1=CC=C(C=O)C2=CC(OC)=CC=C21 PDGKZDPIWAKVLH-UHFFFAOYSA-N 0.000 description 2
- SNUZUAUVNMCODC-UHFFFAOYSA-N 7-fluoro-3-oxo-4h-1,4-benzothiazine-6-carbaldehyde Chemical compound S1CC(=O)NC2=C1C=C(F)C(C=O)=C2 SNUZUAUVNMCODC-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- 241000589291 Acinetobacter Species 0.000 description 2
- 101001053395 Arabidopsis thaliana Acid beta-fructofuranosidase 4, vacuolar Proteins 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 2
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 241000194033 Enterococcus Species 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- 102000020897 Formins Human genes 0.000 description 2
- 108091022623 Formins Proteins 0.000 description 2
- 241000590002 Helicobacter pylori Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- JHPVFFJPSGFQFT-OCCSQVGLSA-N N[C@@H]1CC[C@H](OC1)COC=1C=CC=C2C=CC(=NC12)C#N Chemical compound N[C@@H]1CC[C@H](OC1)COC=1C=CC=C2C=CC(=NC12)C#N JHPVFFJPSGFQFT-OCCSQVGLSA-N 0.000 description 2
- 229910004809 Na2 SO4 Inorganic materials 0.000 description 2
- PEKRPORMYGTOHQ-DWRRFWBPSA-N OC(C(C1=C2C=C(C=NC2=CC=C1)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound OC(C(C1=C2C=C(C=NC2=CC=C1)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O PEKRPORMYGTOHQ-DWRRFWBPSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 238000006619 Stille reaction Methods 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 2
- VKIJXFIYBAYHOE-VOTSOKGWSA-N [(e)-2-phenylethenyl]boronic acid Chemical compound OB(O)\C=C\C1=CC=CC=C1 VKIJXFIYBAYHOE-VOTSOKGWSA-N 0.000 description 2
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 150000003927 aminopyridines Chemical class 0.000 description 2
- 150000001448 anilines Chemical class 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- TUWZZXGAUMSUOB-UHFFFAOYSA-N benzyl piperidine-1-carboxylate Chemical compound C1CCCCN1C(=O)OCC1=CC=CC=C1 TUWZZXGAUMSUOB-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Substances ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- MLIREBYILWEBDM-UHFFFAOYSA-N cyanoacetic acid Chemical compound OC(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-N 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 2
- LJOQGZACKSYWCH-UHFFFAOYSA-N dihydro quinine Natural products C1=C(OC)C=C2C(C(O)C3CC4CCN3CC4CC)=CC=NC2=C1 LJOQGZACKSYWCH-UHFFFAOYSA-N 0.000 description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000036267 drug metabolism Effects 0.000 description 2
- BADWIIDKTXQYLW-UHFFFAOYSA-N ethenylstannane Chemical compound [SnH3]C=C BADWIIDKTXQYLW-UHFFFAOYSA-N 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229940047650 haemophilus influenzae Drugs 0.000 description 2
- 229940037467 helicobacter pylori Drugs 0.000 description 2
- FXHGMKSSBGDXIY-UHFFFAOYSA-N heptanal Chemical compound CCCCCCC=O FXHGMKSSBGDXIY-UHFFFAOYSA-N 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 150000002466 imines Chemical class 0.000 description 2
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 2
- 125000001786 isothiazolyl group Chemical group 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- 239000003120 macrolide antibiotic agent Substances 0.000 description 2
- 229940041033 macrolides Drugs 0.000 description 2
- 229910000474 mercury oxide Inorganic materials 0.000 description 2
- UKWHYYKOEPRTIC-UHFFFAOYSA-N mercury(ii) oxide Chemical compound [Hg]=O UKWHYYKOEPRTIC-UHFFFAOYSA-N 0.000 description 2
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 2
- LSEFCHWGJNHZNT-UHFFFAOYSA-M methyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 LSEFCHWGJNHZNT-UHFFFAOYSA-M 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- ROLDJWUVXBRJKC-UHFFFAOYSA-N n-[bis(dimethylamino)phosphoryl]-n-methylmethanamine;n,n-dimethylformamide Chemical compound CN(C)C=O.CN(C)P(=O)(N(C)C)N(C)C ROLDJWUVXBRJKC-UHFFFAOYSA-N 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000001715 oxadiazolyl group Chemical group 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000003373 pyrazinyl group Chemical group 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- 125000002098 pyridazinyl group Chemical group 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 150000003246 quinazolines Chemical class 0.000 description 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 2
- ZUQDDQFXSNXEOD-UHFFFAOYSA-N quinoxalin-5-ol Chemical compound C1=CN=C2C(O)=CC=CC2=N1 ZUQDDQFXSNXEOD-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- YBCAZPLXEGKKFM-UHFFFAOYSA-K ruthenium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Ru+3] YBCAZPLXEGKKFM-UHFFFAOYSA-K 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical class [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 2
- 239000012453 solvate Substances 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- TZAXOXUWWFVCIR-ZJUUUORDSA-N tert-butyl n-[(3r,6s)-6-(2-oxoethyl)oxan-3-yl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@@H]1CC[C@@H](CC=O)OC1 TZAXOXUWWFVCIR-ZJUUUORDSA-N 0.000 description 2
- LKBZAGUOZDYGKG-BDAKNGLRSA-N tert-butyl n-[(3r,6s)-6-(hydroxymethyl)oxan-3-yl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@@H]1CC[C@@H](CO)OC1 LKBZAGUOZDYGKG-BDAKNGLRSA-N 0.000 description 2
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- 125000001113 thiadiazolyl group Chemical group 0.000 description 2
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 description 2
- 125000000335 thiazolyl group Chemical group 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- NDLIRBZKZSDGSO-UHFFFAOYSA-N tosyl azide Chemical compound CC1=CC=C(S(=O)(=O)[N-][N+]#N)C=C1 NDLIRBZKZSDGSO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 2
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 2
- CLUOHJOKZOUQNK-LBPRGKRZSA-N (1R)-1-(3-methoxyquinolin-5-yl)ethane-1,2-diol Chemical compound COC=1C=NC2=CC=CC(=C2C1)[C@H](CO)O CLUOHJOKZOUQNK-LBPRGKRZSA-N 0.000 description 1
- HFVMEOPYDLEHBR-UHFFFAOYSA-N (2-fluorophenyl)-phenylmethanol Chemical compound C=1C=CC=C(F)C=1C(O)C1=CC=CC=C1 HFVMEOPYDLEHBR-UHFFFAOYSA-N 0.000 description 1
- AFVJQNPGRDLPCM-DTWKUNHWSA-N (2r,5s)-5-methoxycarbonyl-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-2-carboxylic acid Chemical compound COC(=O)[C@H]1CC[C@H](C(O)=O)N(C(=O)OC(C)(C)C)C1 AFVJQNPGRDLPCM-DTWKUNHWSA-N 0.000 description 1
- SHOTUBZKFVJHOH-UHFFFAOYSA-N (3-methoxyquinoxalin-5-yl) trifluoromethanesulfonate Chemical compound C1=CC=C(OS(=O)(=O)C(F)(F)F)C2=NC(OC)=CN=C21 SHOTUBZKFVJHOH-UHFFFAOYSA-N 0.000 description 1
- LLUGOJCCIDDVEX-YPMHNXCESA-N (3r,6s)-6-[(6-methoxyquinolin-4-yl)oxymethyl]oxan-3-amine Chemical compound C12=CC(OC)=CC=C2N=CC=C1OC[C@@H]1CC[C@@H](N)CO1 LLUGOJCCIDDVEX-YPMHNXCESA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- SYWZRENPRMBCHR-UHFFFAOYSA-N (6-methoxyquinolin-4-yl) trifluoromethanesulfonate Chemical compound N1=CC=C(OS(=O)(=O)C(F)(F)F)C2=CC(OC)=CC=C21 SYWZRENPRMBCHR-UHFFFAOYSA-N 0.000 description 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 description 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 1
- SQHSJJGGWYIFCD-UHFFFAOYSA-N (e)-1-diazonio-1-dimethoxyphosphorylprop-1-en-2-olate Chemical compound COP(=O)(OC)C(\[N+]#N)=C(\C)[O-] SQHSJJGGWYIFCD-UHFFFAOYSA-N 0.000 description 1
- QUZMIAJIRIZFQN-UHFFFAOYSA-N (e)-diazo(dimethoxyphosphoryl)methane Chemical compound COP(=O)(OC)C=[N+]=[N-] QUZMIAJIRIZFQN-UHFFFAOYSA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- NDQXKKFRNOPRDW-UHFFFAOYSA-N 1,1,1-triethoxyethane Chemical compound CCOC(C)(OCC)OCC NDQXKKFRNOPRDW-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- XGINAUQXFXVBND-UHFFFAOYSA-N 1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrimidine Chemical compound N1CC=CN2CCCC21 XGINAUQXFXVBND-UHFFFAOYSA-N 0.000 description 1
- YUCBLVFHJWOYDN-PDNPBWJSSA-N 1,4-bis[(r)-[(2s,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methoxy]phthalazine Chemical compound C1=C(OC)C=C2C([C@@H](OC=3C4=CC=CC=C4C(O[C@@H]([C@H]4N5CC[C@H]([C@H](C5)CC)C4)C=4C5=CC(OC)=CC=C5N=CC=4)=NN=3)[C@@H]3C[C@@H]4CCN3C[C@@H]4CC)=CC=NC2=C1 YUCBLVFHJWOYDN-PDNPBWJSSA-N 0.000 description 1
- ZNLAHAOCFKBYRH-UHFFFAOYSA-N 1,4-dioxane-2,3-dione Chemical compound O=C1OCCOC1=O ZNLAHAOCFKBYRH-UHFFFAOYSA-N 0.000 description 1
- RNHDAKUGFHSZEV-UHFFFAOYSA-N 1,4-dioxane;hydrate Chemical compound O.C1COCCO1 RNHDAKUGFHSZEV-UHFFFAOYSA-N 0.000 description 1
- WMKGGPCROCCUDY-UHFFFAOYSA-N 1,5-diphenylpenta-1,4-dien-3-one Chemical compound C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1 WMKGGPCROCCUDY-UHFFFAOYSA-N 0.000 description 1
- KFAJXZVDBVRZRC-UHFFFAOYSA-N 1,5-naphthyridin-4-amine Chemical compound C1=CN=C2C(N)=CC=NC2=C1 KFAJXZVDBVRZRC-UHFFFAOYSA-N 0.000 description 1
- VMLKTERJLVWEJJ-UHFFFAOYSA-N 1,5-naphthyridine Chemical compound C1=CC=NC2=CC=CN=C21 VMLKTERJLVWEJJ-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- PWMWNFMRSKOCEY-UHFFFAOYSA-N 1-Phenyl-1,2-ethanediol Chemical compound OCC(O)C1=CC=CC=C1 PWMWNFMRSKOCEY-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- MICMHFIQSAMEJG-UHFFFAOYSA-N 1-bromopyrrolidine-2,5-dione Chemical compound BrN1C(=O)CCC1=O.BrN1C(=O)CCC1=O MICMHFIQSAMEJG-UHFFFAOYSA-N 0.000 description 1
- UOWIYNWMROWVDG-UHFFFAOYSA-N 1-dimethoxyphosphorylpropan-2-one Chemical compound COP(=O)(OC)CC(C)=O UOWIYNWMROWVDG-UHFFFAOYSA-N 0.000 description 1
- UIQBUOPPWVKGMC-UONOGXRCSA-N 1-o-benzyl 3-o-methyl (3s,6r)-6-(hydroxymethyl)piperidine-1,3-dicarboxylate Chemical compound C1[C@@H](C(=O)OC)CC[C@H](CO)N1C(=O)OCC1=CC=CC=C1 UIQBUOPPWVKGMC-UONOGXRCSA-N 0.000 description 1
- KCEQSLRQZCSSAM-VHSXEESVSA-N 1-o-tert-butyl 3-o-methyl (3s,6r)-6-(hydroxymethyl)piperidine-1,3-dicarboxylate Chemical compound COC(=O)[C@H]1CC[C@H](CO)N(C(=O)OC(C)(C)C)C1 KCEQSLRQZCSSAM-VHSXEESVSA-N 0.000 description 1
- LYYJQMCPEHXOEW-UHFFFAOYSA-N 1-o-tert-butyl 3-o-methyl piperidine-1,3-dicarboxylate Chemical compound COC(=O)C1CCCN(C(=O)OC(C)(C)C)C1 LYYJQMCPEHXOEW-UHFFFAOYSA-N 0.000 description 1
- FFLPIVZNYJKKDM-UHFFFAOYSA-N 1-phenylmethoxycarbonylpiperidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CCCN1C(=O)OCC1=CC=CC=C1 FFLPIVZNYJKKDM-UHFFFAOYSA-N 0.000 description 1
- GRNOZCCBOFGDCL-UHFFFAOYSA-N 2,2,2-trichloroacetyl isocyanate Chemical compound ClC(Cl)(Cl)C(=O)N=C=O GRNOZCCBOFGDCL-UHFFFAOYSA-N 0.000 description 1
- HEWZVZIVELJPQZ-UHFFFAOYSA-N 2,2-dimethoxypropane Chemical compound COC(C)(C)OC HEWZVZIVELJPQZ-UHFFFAOYSA-N 0.000 description 1
- YBOYSAPIYLFSMD-UHFFFAOYSA-N 2,2-dimethyl-3,4-dihydrochromene-7-carbaldehyde Chemical compound C1=C(C=O)C=C2OC(C)(C)CCC2=C1 YBOYSAPIYLFSMD-UHFFFAOYSA-N 0.000 description 1
- ZYBZYDVRLQSWGG-UHFFFAOYSA-N 2,2-dimethyloct-7-enoic acid Chemical compound OC(=O)C(C)(C)CCCCC=C ZYBZYDVRLQSWGG-UHFFFAOYSA-N 0.000 description 1
- HMBHAQMOBKLWRX-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodioxine-3-carboxylic acid Chemical compound C1=CC=C2OC(C(=O)O)COC2=C1 HMBHAQMOBKLWRX-UHFFFAOYSA-N 0.000 description 1
- BPRYUXCVCCNUFE-UHFFFAOYSA-N 2,4,6-trimethylphenol Chemical compound CC1=CC(C)=C(O)C(C)=C1 BPRYUXCVCCNUFE-UHFFFAOYSA-N 0.000 description 1
- OWOUQNFQFVZFEP-UHFFFAOYSA-N 2-(1-phenylmethoxycarbonylpiperidin-3-yl)oxyacetic acid Chemical compound C1C(OCC(=O)O)CCCN1C(=O)OCC1=CC=CC=C1 OWOUQNFQFVZFEP-UHFFFAOYSA-N 0.000 description 1
- ZWKJGSFAORXDED-UHFFFAOYSA-N 2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethanol Chemical compound O1CCOC2=CC(CCO)=CC=C21 ZWKJGSFAORXDED-UHFFFAOYSA-N 0.000 description 1
- ODLUBLURAWVYJD-UHFFFAOYSA-N 2-(2-bromoethylsulfanyl)thiophene Chemical compound BrCCSC1=CC=CS1 ODLUBLURAWVYJD-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- UUNIOFWUJYBVGQ-UHFFFAOYSA-N 2-amino-4-(3,4-dimethoxyphenyl)-10-fluoro-4,5,6,7-tetrahydrobenzo[1,2]cyclohepta[6,7-d]pyran-3-carbonitrile Chemical compound C1=C(OC)C(OC)=CC=C1C1C(C#N)=C(N)OC2=C1CCCC1=CC=C(F)C=C12 UUNIOFWUJYBVGQ-UHFFFAOYSA-N 0.000 description 1
- DUMCRDRGCPPVSM-UHFFFAOYSA-N 2-chloro-1-(3,4-dihydro-2h-1,4-benzothiazin-6-yl)ethanone Chemical compound S1CCNC2=CC(C(=O)CCl)=CC=C21 DUMCRDRGCPPVSM-UHFFFAOYSA-N 0.000 description 1
- NXYFPLVZSNIKPI-UHFFFAOYSA-N 2-cyano-n-(2-methyl-6-nitrophenyl)acetamide Chemical compound CC1=CC=CC([N+]([O-])=O)=C1NC(=O)CC#N NXYFPLVZSNIKPI-UHFFFAOYSA-N 0.000 description 1
- KXSOCSKZJXBVCT-UHFFFAOYSA-N 2-ethenyl-6-methoxybenzene-1,4-diol Chemical compound COC=1C=C(O)C=C(C1O)C=C KXSOCSKZJXBVCT-UHFFFAOYSA-N 0.000 description 1
- KBSMXRAGKAYNAB-UHFFFAOYSA-N 2-methoxy-8-(2-phenylethenyl)-1,5-naphthyridine Chemical compound C12=NC(OC)=CC=C2N=CC=C1C=CC1=CC=CC=C1 KBSMXRAGKAYNAB-UHFFFAOYSA-N 0.000 description 1
- AJWJCDDMGBKWAW-UHFFFAOYSA-N 2-methoxyquinolin-8-ol Chemical compound C1=CC=C(O)C2=NC(OC)=CC=C21 AJWJCDDMGBKWAW-UHFFFAOYSA-N 0.000 description 1
- FCMRHMPITHLLLA-UHFFFAOYSA-N 2-methyl-6-nitroaniline Chemical compound CC1=CC=CC([N+]([O-])=O)=C1N FCMRHMPITHLLLA-UHFFFAOYSA-N 0.000 description 1
- UHPGVDHXHDPYQP-UHFFFAOYSA-N 2-methyl-8-nitroquinoline Chemical compound C1=CC=C([N+]([O-])=O)C2=NC(C)=CC=C21 UHPGVDHXHDPYQP-UHFFFAOYSA-N 0.000 description 1
- NLXZSCLYIUHXMF-UHFFFAOYSA-N 2-oxo-1h-pyrido[3,4-b][1,4]oxazine-7-carbaldehyde Chemical compound N1C(=O)COC2=C1C=C(C=O)N=C2 NLXZSCLYIUHXMF-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- MHKLNUUEKJHPHP-UHFFFAOYSA-N 2h-1,4-thiazine-6-carboxylic acid Chemical compound OC(=O)C1=CN=CCS1 MHKLNUUEKJHPHP-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- WDOAICBPKNQVSB-UHFFFAOYSA-N 3-(aminomethyl)-n-(6-methoxy-1,5-naphthyridin-4-yl)cyclohexane-1-carboxamide Chemical compound C12=NC(OC)=CC=C2N=CC=C1NC(=O)C1CCCC(CN)C1 WDOAICBPKNQVSB-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ZGIKWINFUGEQEO-UHFFFAOYSA-N 3-bromoquinoline Chemical compound C1=CC=CC2=CC(Br)=CN=C21 ZGIKWINFUGEQEO-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- RDNOZYLIMZPTDV-UHFFFAOYSA-N 3-chloro-6-methoxy-1h-quinolin-4-one Chemical compound N1=CC(Cl)=C(O)C2=CC(OC)=CC=C21 RDNOZYLIMZPTDV-UHFFFAOYSA-N 0.000 description 1
- VUJRFAGCRMFKPZ-UHFFFAOYSA-N 3-hydroxy-1,2,4,3lambda5-trioxaphospholane 3-oxide Chemical compound OP1(=O)OCOO1 VUJRFAGCRMFKPZ-UHFFFAOYSA-N 0.000 description 1
- FLQPQOIGLVLFDY-UHFFFAOYSA-N 3-methoxy-5-(oxiran-2-yl)quinoline Chemical compound C12=CC(OC)=CN=C2C=CC=C1C1CO1 FLQPQOIGLVLFDY-UHFFFAOYSA-N 0.000 description 1
- LYPGPVFFVUJFEV-UHFFFAOYSA-N 3-methoxyquinoxalin-5-ol Chemical compound C1=CC=C(O)C2=NC(OC)=CN=C21 LYPGPVFFVUJFEV-UHFFFAOYSA-N 0.000 description 1
- NDEZTSHWEPQVBX-UHFFFAOYSA-N 4-(difluoromethoxy)aniline Chemical compound NC1=CC=C(OC(F)F)C=C1 NDEZTSHWEPQVBX-UHFFFAOYSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- 150000005011 4-aminoquinolines Chemical class 0.000 description 1
- QISOBCMNUJQOJU-UHFFFAOYSA-N 4-bromo-1h-pyrazole-5-carboxylic acid Chemical compound OC(=O)C=1NN=CC=1Br QISOBCMNUJQOJU-UHFFFAOYSA-N 0.000 description 1
- UXSHMFZAQNCVGK-UHFFFAOYSA-N 4-bromo-3-chloro-6-methoxyquinoline Chemical compound N1=CC(Cl)=C(Br)C2=CC(OC)=CC=C21 UXSHMFZAQNCVGK-UHFFFAOYSA-N 0.000 description 1
- BNNMDMGPZUOOOE-UHFFFAOYSA-N 4-methylbenzenesulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1.CC1=CC=C(S(O)(=O)=O)C=C1 BNNMDMGPZUOOOE-UHFFFAOYSA-N 0.000 description 1
- GTFMIJNXNMDHAB-UHFFFAOYSA-N 4h-1,4-benzothiazin-3-one Chemical compound C1=CC=C2NC(=O)CSC2=C1 GTFMIJNXNMDHAB-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- 125000006043 5-hexenyl group Chemical group 0.000 description 1
- YDYLPMPVYALQKQ-UHFFFAOYSA-N 6-(2-chloroacetyl)-4h-1,4-benzothiazin-3-one Chemical compound S1CC(=O)NC2=CC(C(=O)CCl)=CC=C21 YDYLPMPVYALQKQ-UHFFFAOYSA-N 0.000 description 1
- MIAHXWVABDHISZ-UHFFFAOYSA-N 6-(2-chloroacetyl)-4h-1,4-benzoxazin-3-one Chemical compound O1CC(=O)NC2=CC(C(=O)CCl)=CC=C21 MIAHXWVABDHISZ-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- XMXIESNDLPBKFZ-UHFFFAOYSA-N 6-(difluoromethoxy)-1h-quinolin-4-one Chemical compound N1C=CC(=O)C2=CC(OC(F)F)=CC=C21 XMXIESNDLPBKFZ-UHFFFAOYSA-N 0.000 description 1
- LFCAVZDSLWEEOX-UHFFFAOYSA-N 6-(trifluoromethoxy)-1h-quinolin-4-one Chemical compound N1C=CC(=O)C2=CC(OC(F)(F)F)=CC=C21 LFCAVZDSLWEEOX-UHFFFAOYSA-N 0.000 description 1
- YGBJEMKDGOMXMG-IKGYGIMUSA-N 6-[[[(3r,6s)-6-[(e)-2-(3-methoxyquinolin-5-yl)ethenyl]oxan-3-yl]amino]methyl]-4h-1,4-benzothiazin-3-one Chemical compound S1CC(=O)NC2=CC(CN[C@@H]3CC[C@H](OC3)/C=C/C3=CC=CC4=NC=C(C=C43)OC)=CC=C21 YGBJEMKDGOMXMG-IKGYGIMUSA-N 0.000 description 1
- PQKLUHLXOGDASP-UHFFFAOYSA-N 6-fluoro-3-oxo-4h-1,4-benzothiazine-7-carbaldehyde Chemical compound N1C(=O)CSC2=C1C=C(F)C(C=O)=C2 PQKLUHLXOGDASP-UHFFFAOYSA-N 0.000 description 1
- TZRSKDVHKGYCON-UHFFFAOYSA-N 6-methoxy-4-(oxiran-2-yl)quinoline Chemical compound C12=CC(OC)=CC=C2N=CC=C1C1CO1 TZRSKDVHKGYCON-UHFFFAOYSA-N 0.000 description 1
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Chemical class 0.000 description 1
- USVZHTBPMMSRHY-UHFFFAOYSA-N 8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9-[2-(2-chlorophenyl)ethyl]purin-6-amine Chemical compound C=1C=2OCOC=2C=C(Br)C=1SC1=NC=2C(N)=NC=NC=2N1CCC1=CC=CC=C1Cl USVZHTBPMMSRHY-UHFFFAOYSA-N 0.000 description 1
- ROHNLVXQIAQBHB-UHFFFAOYSA-N 8-fluoro-6-methoxy-1h-quinolin-4-one Chemical compound N1C=CC(=O)C2=CC(OC)=CC(F)=C21 ROHNLVXQIAQBHB-UHFFFAOYSA-N 0.000 description 1
- NZKPWVAKHWJDAX-UHFFFAOYSA-N 8-methyl-1h-quinoxalin-2-one Chemical compound C1=C(O)N=C2C(C)=CC=CC2=N1 NZKPWVAKHWJDAX-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- 241000606750 Actinobacillus Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- AXXLAOYVJJFFKW-UHFFFAOYSA-N B1CCCCCCCC1C1CCCCCCCC1 Chemical compound B1CCCCCCCC1C1CCCCCCCC1 AXXLAOYVJJFFKW-UHFFFAOYSA-N 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 241001148536 Bacteroides sp. Species 0.000 description 1
- 241001518086 Bartonella henselae Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 241000180135 Borrelia recurrentis Species 0.000 description 1
- 241000589969 Borreliella burgdorferi Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 238000006443 Buchwald-Hartwig cross coupling reaction Methods 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- CLYFOKKGNLRIFR-RISCZKNCSA-N C(#N)C1=NC2=C(C=CC=C2C=C1)NC(=O)[C@H]1OC[C@@H](CC1)N Chemical compound C(#N)C1=NC2=C(C=CC=C2C=C1)NC(=O)[C@H]1OC[C@@H](CC1)N CLYFOKKGNLRIFR-RISCZKNCSA-N 0.000 description 1
- KEWXTLXDVCKJCG-HIFRSBDPSA-N C(C)(C)(C)OC(N[C@H]1CO[C@@H](C=C1)COC1=NC=NC2=CC=C(C=C12)OC)=O Chemical compound C(C)(C)(C)OC(N[C@H]1CO[C@@H](C=C1)COC1=NC=NC2=CC=C(C=C12)OC)=O KEWXTLXDVCKJCG-HIFRSBDPSA-N 0.000 description 1
- OJRUSAPKCPIVBY-KQYNXXCUSA-N C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N Chemical compound C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N OJRUSAPKCPIVBY-KQYNXXCUSA-N 0.000 description 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 1
- CROFLZCNMRIGFP-QWHCGFSZSA-N COC(=O)[C@H]1CC[C@@H](N(C1)C(=O)OCC1=CC=CC=C1)C(=O)O Chemical compound COC(=O)[C@H]1CC[C@@H](N(C1)C(=O)OCC1=CC=CC=C1)C(=O)O CROFLZCNMRIGFP-QWHCGFSZSA-N 0.000 description 1
- MANCTBIAQJEDLC-YGXGPUHLSA-N COC=1C=C2C(=CC=NC2=CC1)/C=C/[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1 Chemical compound COC=1C=C2C(=CC=NC2=CC1)/C=C/[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1 MANCTBIAQJEDLC-YGXGPUHLSA-N 0.000 description 1
- UZNXJVKZXAURHX-GVCORALISA-N COC=1C=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H]([C@H](O1)CC(=O)O)NCC=1C=CC2=C(NC(CO2)=O)C1 Chemical compound COC=1C=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H]([C@H](O1)CC(=O)O)NCC=1C=CC2=C(NC(CO2)=O)C1 UZNXJVKZXAURHX-GVCORALISA-N 0.000 description 1
- LOVVTRINTNLSBZ-RZPHLTDDSA-N COC=1C=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H]([C@H](O1)CC(=O)O)NCC=1C=CC2=C(NC(CS2)=O)C1 Chemical compound COC=1C=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H]([C@H](O1)CC(=O)O)NCC=1C=CC2=C(NC(CS2)=O)C1 LOVVTRINTNLSBZ-RZPHLTDDSA-N 0.000 description 1
- GXEIZGJKOQLJFX-SXSPYAJSSA-N COC=1C=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H]([C@H](O1)CC(=O)O)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound COC=1C=C2C(=CC=NC2=CC1)CC[C@@H]1CC[C@H]([C@H](O1)CC(=O)O)NCC=1C=CC=2SCC(NC2N1)=O GXEIZGJKOQLJFX-SXSPYAJSSA-N 0.000 description 1
- XVJNPQMIRQWLFC-UXHICEINSA-N COC=1C=C2C(=CC=NC2=CC1)CC[C@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1 Chemical compound COC=1C=C2C(=CC=NC2=CC1)CC[C@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1 XVJNPQMIRQWLFC-UXHICEINSA-N 0.000 description 1
- ATPPWLOWFZEMHD-MOPGFXCFSA-N COC=1C=C2C(=CC=NC2=CC1)CC[C@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound COC=1C=C2C(=CC=NC2=CC1)CC[C@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O ATPPWLOWFZEMHD-MOPGFXCFSA-N 0.000 description 1
- LVAOBPIIEUFKIK-ZBFHGGJFSA-N COC=1C=C2C(=CC=NC2=CC1)OC[C@@H]1CC[C@H](CO1)NCC(=O)NC=1SC=CN1 Chemical compound COC=1C=C2C(=CC=NC2=CC1)OC[C@@H]1CC[C@H](CO1)NCC(=O)NC=1SC=CN1 LVAOBPIIEUFKIK-ZBFHGGJFSA-N 0.000 description 1
- AWQJJJUAPLKFOU-RZPHLTDDSA-N COC=1C=NC2=CC=CC(=C2C1)CC[C@@H]1CC[C@H]([C@H](O1)CC(=O)O)NCC=1C=CC2=C(NC(CS2)=O)C1 Chemical compound COC=1C=NC2=CC=CC(=C2C1)CC[C@@H]1CC[C@H]([C@H](O1)CC(=O)O)NCC=1C=CC2=C(NC(CS2)=O)C1 AWQJJJUAPLKFOU-RZPHLTDDSA-N 0.000 description 1
- RPISZQWNZLTZOP-SXSPYAJSSA-N COC=1C=NC2=CC=CC(=C2C1)CC[C@@H]1CC[C@H]([C@H](O1)CC(=O)O)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound COC=1C=NC2=CC=CC(=C2C1)CC[C@@H]1CC[C@H]([C@H](O1)CC(=O)O)NCC=1C=CC=2SCC(NC2N1)=O RPISZQWNZLTZOP-SXSPYAJSSA-N 0.000 description 1
- 101100167365 Caenorhabditis elegans cha-1 gene Proteins 0.000 description 1
- 101100021265 Caenorhabditis elegans lin-5 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 241001432959 Chernes Species 0.000 description 1
- 241001647372 Chlamydia pneumoniae Species 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 238000005811 Corey-Fuchs synthesis reaction Methods 0.000 description 1
- 241001518260 Corynebacterium minutissimum Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000008953 Cryptosporidiosis Diseases 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 1
- 101710198144 Endopolygalacturonase I Proteins 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241000520130 Enterococcus durans Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Natural products OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 201000000628 Gas Gangrene Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 241000222722 Leishmania <genus> Species 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000010315 Mastoiditis Diseases 0.000 description 1
- 238000006751 Mitsunobu reaction Methods 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000588655 Moraxella catarrhalis Species 0.000 description 1
- 241000186367 Mycobacterium avium Species 0.000 description 1
- 241000513886 Mycobacterium avium complex (MAC) Species 0.000 description 1
- 241000187482 Mycobacterium avium subsp. paratuberculosis Species 0.000 description 1
- 241000187478 Mycobacterium chelonae Species 0.000 description 1
- 241000186364 Mycobacterium intracellulare Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- HIYFMBHLWDYVIL-PWBPUHETSA-N N[C@@H]1CC[C@H](OC1)C(CC1=CC=NC2=CC=C(C=C12)OC)O Chemical compound N[C@@H]1CC[C@H](OC1)C(CC1=CC=NC2=CC=C(C=C12)OC)O HIYFMBHLWDYVIL-PWBPUHETSA-N 0.000 description 1
- QKHFRXLORDCIIK-DQYPLSBCSA-N N[C@@H]1CC[C@H](OC1)[C@H](CC1=C2C=C(C=NC2=CC=C1)OC)O Chemical compound N[C@@H]1CC[C@H](OC1)[C@H](CC1=C2C=C(C=NC2=CC=C1)OC)O QKHFRXLORDCIIK-DQYPLSBCSA-N 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- 241000588650 Neisseria meningitidis Species 0.000 description 1
- JNYNDDCSXXFKBP-NUOBJKKLSA-N O1CCOC2=C1C=CC(=C2)CN[C@@H]2CC[C@H](OC2)C(C(O)C2=C1C=C(C=NC1=CC=C2)OC)O Chemical compound O1CCOC2=C1C=CC(=C2)CN[C@@H]2CC[C@H](OC2)C(C(O)C2=C1C=C(C=NC1=CC=C2)OC)O JNYNDDCSXXFKBP-NUOBJKKLSA-N 0.000 description 1
- HKVIYGZPXOBITK-NUOBJKKLSA-N O1CCOC2=C1C=CC(=C2)CN[C@@H]2CC[C@H](OC2)C(C(O)C2=CC=NC1=CC=C(C=C21)OC)O Chemical compound O1CCOC2=C1C=CC(=C2)CN[C@@H]2CC[C@H](OC2)C(C(O)C2=CC=NC1=CC=C(C=C21)OC)O HKVIYGZPXOBITK-NUOBJKKLSA-N 0.000 description 1
- RQDNUVRMIQWOHU-NHCUHLMSSA-N O1CCOC2=C1C=CC(=C2)CN[C@H]2CO[C@@H](CC2)C=CC2=CC=NC1=CC=C(C=C21)OC Chemical compound O1CCOC2=C1C=CC(=C2)CN[C@H]2CO[C@@H](CC2)C=CC2=CC=NC1=CC=C(C=C21)OC RQDNUVRMIQWOHU-NHCUHLMSSA-N 0.000 description 1
- XEYHQVNBGFJAKZ-RTWAWAEBSA-N O1CCOC2=C1C=CC(=C2)CN[C@H]2CO[C@H](CC2)CCC2=C1C=C(C=NC1=CC=C2)OC Chemical compound O1CCOC2=C1C=CC(=C2)CN[C@H]2CO[C@H](CC2)CCC2=C1C=C(C=NC1=CC=C2)OC XEYHQVNBGFJAKZ-RTWAWAEBSA-N 0.000 description 1
- ZRIDAVXRQKPGRB-RTWAWAEBSA-N O1CCOC2=C1C=CC(=C2)CN[C@H]2CO[C@H](CC2)CCC2=CC=NC1=CC=C(C=C21)OC Chemical compound O1CCOC2=C1C=CC(=C2)CN[C@H]2CO[C@H](CC2)CCC2=CC=NC1=CC=C(C=C21)OC ZRIDAVXRQKPGRB-RTWAWAEBSA-N 0.000 description 1
- ORVUAUSTYVMBLO-OLLUBJOZSA-N O1CCOC2=C1C=CC(=C2)CN[C@H]2[C@H](O[C@@H](CC2)CCC2=C1C=C(C=NC1=CC=C2)OC)CC(=O)O Chemical compound O1CCOC2=C1C=CC(=C2)CN[C@H]2[C@H](O[C@@H](CC2)CCC2=C1C=C(C=NC1=CC=C2)OC)CC(=O)O ORVUAUSTYVMBLO-OLLUBJOZSA-N 0.000 description 1
- XLHRXZQWLVZDMP-OLLUBJOZSA-N O1CCOC2=C1C=CC(=C2)CN[C@H]2[C@H](O[C@@H](CC2)CCC2=CC=NC1=CC=C(C=C21)OC)CC(=O)O Chemical compound O1CCOC2=C1C=CC(=C2)CN[C@H]2[C@H](O[C@@H](CC2)CCC2=CC=NC1=CC=C(C=C21)OC)CC(=O)O XLHRXZQWLVZDMP-OLLUBJOZSA-N 0.000 description 1
- LEBVIJXEVPNHFX-UXHICEINSA-N O1CCOC2=NC(=CC=C21)CN[C@H]2CO[C@H](CC2)CCC2=C1C=C(C=NC1=CC=C2)OC Chemical compound O1CCOC2=NC(=CC=C21)CN[C@H]2CO[C@H](CC2)CCC2=C1C=C(C=NC1=CC=C2)OC LEBVIJXEVPNHFX-UXHICEINSA-N 0.000 description 1
- RYYKGZSQAIFVPZ-UXHICEINSA-N O1CCOC2=NC(=CC=C21)CN[C@H]2CO[C@H](CC2)CCC2=CC=NC1=CC=C(C=C21)OC Chemical compound O1CCOC2=NC(=CC=C21)CN[C@H]2CO[C@H](CC2)CCC2=CC=NC1=CC=C(C=C21)OC RYYKGZSQAIFVPZ-UXHICEINSA-N 0.000 description 1
- GLHAYMGVULCHMU-RZPHLTDDSA-N O1CCOC2=NC(=CC=C21)CN[C@H]2[C@H](O[C@@H](CC2)CCC2=C1C=C(C=NC1=CC=C2)OC)CC(=O)O Chemical compound O1CCOC2=NC(=CC=C21)CN[C@H]2[C@H](O[C@@H](CC2)CCC2=C1C=C(C=NC1=CC=C2)OC)CC(=O)O GLHAYMGVULCHMU-RZPHLTDDSA-N 0.000 description 1
- SRJGVULTASYVFN-RZPHLTDDSA-N O1CCOC2=NC(=CC=C21)CN[C@H]2[C@H](O[C@@H](CC2)CCC2=CC=NC1=CC=C(C=C21)OC)CC(=O)O Chemical compound O1CCOC2=NC(=CC=C21)CN[C@H]2[C@H](O[C@@H](CC2)CCC2=CC=NC1=CC=C(C=C21)OC)CC(=O)O SRJGVULTASYVFN-RZPHLTDDSA-N 0.000 description 1
- MDZYXFHAKQFUBE-QUCCMNQESA-N O1CCOC=2C=NC(=CC21)CN[C@H]2CO[C@H](CC2)CCC2=C1C=C(C=NC1=CC=C2)OC Chemical compound O1CCOC=2C=NC(=CC21)CN[C@H]2CO[C@H](CC2)CCC2=C1C=C(C=NC1=CC=C2)OC MDZYXFHAKQFUBE-QUCCMNQESA-N 0.000 description 1
- QFWUSXWQBXKMRF-QUCCMNQESA-N O1CCOC=2C=NC(=CC21)CN[C@H]2CO[C@H](CC2)CCC2=CC=NC1=CC=C(C=C21)OC Chemical compound O1CCOC=2C=NC(=CC21)CN[C@H]2CO[C@H](CC2)CCC2=CC=NC1=CC=C(C=C21)OC QFWUSXWQBXKMRF-QUCCMNQESA-N 0.000 description 1
- XYIAUJJCMMPIQE-CTUHWIOQSA-N O1CCOC=2C=NC(=CC21)CN[C@H]2[C@H](O[C@@H](CC2)CCC2=C1C=C(C=NC1=CC=C2)OC)CC(=O)O Chemical compound O1CCOC=2C=NC(=CC21)CN[C@H]2[C@H](O[C@@H](CC2)CCC2=C1C=C(C=NC1=CC=C2)OC)CC(=O)O XYIAUJJCMMPIQE-CTUHWIOQSA-N 0.000 description 1
- DJCXGHGRSCDOLM-CTUHWIOQSA-N O1CCOC=2C=NC(=CC21)CN[C@H]2[C@H](O[C@@H](CC2)CCC2=CC=NC1=CC=C(C=C21)OC)CC(=O)O Chemical compound O1CCOC=2C=NC(=CC21)CN[C@H]2[C@H](O[C@@H](CC2)CCC2=CC=NC1=CC=C(C=C21)OC)CC(=O)O DJCXGHGRSCDOLM-CTUHWIOQSA-N 0.000 description 1
- WVPCHSCJJMWKAS-GELUABMTSA-N OC(C(C1=C2C=C(C=NC2=CC=C1)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1 Chemical compound OC(C(C1=C2C=C(C=NC2=CC=C1)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1 WVPCHSCJJMWKAS-GELUABMTSA-N 0.000 description 1
- FIMWQDTWMOQGHE-GELUABMTSA-N OC(C(C1=CC=NC2=CC=C(C=C12)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1 Chemical compound OC(C(C1=CC=NC2=CC=C(C=C12)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1 FIMWQDTWMOQGHE-GELUABMTSA-N 0.000 description 1
- VRFITDGPZRXYCL-UNKWYQLESA-N OC(C(C1=CC=NC2=CC=C(C=C12)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CS2)=O)C1 Chemical compound OC(C(C1=CC=NC2=CC=C(C=C12)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CS2)=O)C1 VRFITDGPZRXYCL-UNKWYQLESA-N 0.000 description 1
- HPAZHEGIKZGDCM-DWRRFWBPSA-N OC(C(C1=CC=NC2=CC=C(C=C12)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O Chemical compound OC(C(C1=CC=NC2=CC=C(C=C12)OC)O)[C@@H]1CC[C@H](CO1)NCC=1C=CC=2SCC(NC2N1)=O HPAZHEGIKZGDCM-DWRRFWBPSA-N 0.000 description 1
- OSWNSANOQULBFL-IHHKOXMGSA-N OC(C[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1)C1=C2C=C(C=NC2=CC=C1)OC Chemical compound OC(C[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1)C1=C2C=C(C=NC2=CC=C1)OC OSWNSANOQULBFL-IHHKOXMGSA-N 0.000 description 1
- HWGDSCWIRQPKOI-HJZDTSKPSA-N OC(C[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1)C1=CC=NC2=CC=C(C=C12)OC Chemical compound OC(C[C@@H]1CC[C@H](CO1)NCC=1C=CC2=C(NC(CO2)=O)C1)C1=CC=NC2=CC=C(C=C12)OC HWGDSCWIRQPKOI-HJZDTSKPSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- CUSDBAARXLEPDT-MBOZVWFJSA-N OCC[C@H]1O[C@@H](CC[C@H]1NC(=O)C=1C=CC=2SCC(NC2N1)=O)CCC1=CC=NC2=CC=C(N=C12)OC Chemical compound OCC[C@H]1O[C@@H](CC[C@H]1NC(=O)C=1C=CC=2SCC(NC2N1)=O)CCC1=CC=NC2=CC=C(N=C12)OC CUSDBAARXLEPDT-MBOZVWFJSA-N 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 241000191992 Peptostreptococcus Species 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 241000223960 Plasmodium falciparum Species 0.000 description 1
- 241000233872 Pneumocystis carinii Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 101710191566 Probable endopolygalacturonase I Proteins 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- 206010037075 Protozoal infections Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037294 Puerperal pyrexia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 208000036366 Sensation of pressure Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 206010062255 Soft tissue infection Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193985 Streptococcus agalactiae Species 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 238000006069 Suzuki reaction reaction Methods 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 206010044248 Toxic shock syndrome Diseases 0.000 description 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
- 241000589886 Treponema Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000223105 Trypanosoma brucei Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 241000202921 Ureaplasma urealyticum Species 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 238000007295 Wittig olefination reaction Methods 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- LLPWGHLVUPBSLP-UTUOFQBUSA-N [(2r,3s,4r)-3,4-diacetyloxy-3,4-dihydro-2h-pyran-2-yl]methyl acetate Chemical compound CC(=O)OC[C@H]1OC=C[C@@H](OC(C)=O)[C@@H]1OC(C)=O LLPWGHLVUPBSLP-UTUOFQBUSA-N 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- 241000606834 [Haemophilus] ducreyi Species 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- RAFKCLFWELPONH-UHFFFAOYSA-N acetonitrile;dichloromethane Chemical compound CC#N.ClCCl RAFKCLFWELPONH-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 125000005213 alkyl heteroaryl group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000001483 arginine derivatives Chemical class 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 229940072293 axid Drugs 0.000 description 1
- IUKQLMGVFMDQDP-UHFFFAOYSA-N azane;piperidine Chemical compound N.C1CCNCC1 IUKQLMGVFMDQDP-UHFFFAOYSA-N 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 229940092524 bartonella henselae Drugs 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 125000004190 benzothiazol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N=C(*)SC2=C1[H] 0.000 description 1
- NZEKXBGXMBWXTG-UHFFFAOYSA-N benzyl 3-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethoxy]piperidine-1-carboxylate Chemical compound C1C(OCC(=O)OC(C)(C)C)CCCN1C(=O)OCC1=CC=CC=C1 NZEKXBGXMBWXTG-UHFFFAOYSA-N 0.000 description 1
- BACJRCSSTNDBAP-UHFFFAOYSA-N benzyl N-[6-(2-tert-butylsilyloxypropan-2-yl)piperidin-3-yl]carbamate Chemical compound C(C1=CC=CC=C1)OC(=O)NC1CCC(NC1)C(O[SiH2]C(C)(C)C)(C)C BACJRCSSTNDBAP-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- AZWXAPCAJCYGIA-UHFFFAOYSA-N bis(2-methylpropyl)alumane Chemical compound CC(C)C[AlH]CC(C)C AZWXAPCAJCYGIA-UHFFFAOYSA-N 0.000 description 1
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 1
- JFIOVJDNOJYLKP-UHFFFAOYSA-N bithionol Chemical compound OC1=C(Cl)C=C(Cl)C=C1SC1=CC(Cl)=CC(Cl)=C1O JFIOVJDNOJYLKP-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- GJPICJJJRGTNOD-UHFFFAOYSA-N bosentan Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCO)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 GJPICJJJRGTNOD-UHFFFAOYSA-N 0.000 description 1
- 229960003065 bosentan Drugs 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 101150059448 cdk7 gene Proteins 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004296 chiral HPLC Methods 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- LNAMMBFJMYMQTO-FNEBRGMMSA-N chloroform;(1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].ClC(Cl)Cl.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 LNAMMBFJMYMQTO-FNEBRGMMSA-N 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- 229940075419 choline hydroxide Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000004981 cycloalkylmethyl group Chemical group 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000004984 dialkylaminoalkoxy group Chemical group 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 1
- YDVNLQGCLLPHAH-UHFFFAOYSA-N dichloromethane;hydrate Chemical compound O.ClCCl YDVNLQGCLLPHAH-UHFFFAOYSA-N 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- LTMHNWPUDSTBKD-UHFFFAOYSA-N diethyl 2-(ethoxymethylidene)propanedioate Chemical compound CCOC=C(C(=O)OCC)C(=O)OCC LTMHNWPUDSTBKD-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 description 1
- 238000005906 dihydroxylation reaction Methods 0.000 description 1
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 1
- JMRYOSQOYJBDOI-UHFFFAOYSA-N dilithium;di(propan-2-yl)azanide Chemical compound [Li+].CC(C)[N-]C(C)C.CC(C)N([Li])C(C)C JMRYOSQOYJBDOI-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 1
- JMVOCSLPMGHXPG-UHFFFAOYSA-N dipotassium;dioxido(dioxo)osmium Chemical compound [K+].[K+].[O-][Os]([O-])(=O)=O JMVOCSLPMGHXPG-UHFFFAOYSA-N 0.000 description 1
- DGODWNOPHMXOTR-UHFFFAOYSA-N dipotassium;dioxido(dioxo)osmium;dihydrate Chemical compound O.O.[K+].[K+].[O-][Os]([O-])(=O)=O DGODWNOPHMXOTR-UHFFFAOYSA-N 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical compound [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 description 1
- CETRZFQIITUQQL-UHFFFAOYSA-N dmso dimethylsulfoxide Chemical compound CS(C)=O.CS(C)=O CETRZFQIITUQQL-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 238000006735 epoxidation reaction Methods 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 229940031098 ethanolamine Drugs 0.000 description 1
- FTKASJMIPSSXBP-UHFFFAOYSA-N ethyl 2-nitroacetate Chemical compound CCOC(=O)C[N+]([O-])=O FTKASJMIPSSXBP-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- 229940012017 ethylenediamine Drugs 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 125000004404 heteroalkyl group Chemical group 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- LSXRQJWRXAOUIA-UHFFFAOYSA-N hexan-3-ol Chemical compound CCCC(O)CC.CCCC(O)CC LSXRQJWRXAOUIA-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000007163 homologation reaction Methods 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 238000006197 hydroboration reaction Methods 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229960000811 hydroquinidine Drugs 0.000 description 1
- 229960004251 hydroquinine Drugs 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000008263 liquid aerosol Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium;hydroxide;hydrate Chemical compound [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
- NJCBOMBOMCXCRM-UHFFFAOYSA-N lithium;trimethyl(trimethylsilyl)silane Chemical compound [Li].C[Si](C)(C)[Si](C)(C)C NJCBOMBOMCXCRM-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- BCVXHSPFUWZLGQ-UHFFFAOYSA-N mecn acetonitrile Chemical compound CC#N.CC#N BCVXHSPFUWZLGQ-UHFFFAOYSA-N 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- GXHFUVWIGNLZSC-UHFFFAOYSA-N meldrum's acid Chemical compound CC1(C)OC(=O)CC(=O)O1 GXHFUVWIGNLZSC-UHFFFAOYSA-N 0.000 description 1
- COTNUBDHGSIOTA-UHFFFAOYSA-N meoh methanol Chemical compound OC.OC COTNUBDHGSIOTA-UHFFFAOYSA-N 0.000 description 1
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- SPAKMVQVTSVXES-UHFFFAOYSA-N methanol;oxolane;hydrate Chemical compound O.OC.C1CCOC1 SPAKMVQVTSVXES-UHFFFAOYSA-N 0.000 description 1
- MXDNEPDJMODRAI-VIFPVBQESA-N methyl (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]hex-5-enoate Chemical compound C=CCC[C@@H](C(=O)OC)NC(=O)OC(C)(C)C MXDNEPDJMODRAI-VIFPVBQESA-N 0.000 description 1
- YQYBCXIWRNMCCG-UHFFFAOYSA-N methyl 5-(nitromethyl)cyclohex-3-ene-1-carboxylate Chemical compound COC(=O)C1CC=CC(C[N+]([O-])=O)C1 YQYBCXIWRNMCCG-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- XYDYWTJEGDZLTH-UHFFFAOYSA-N methylenetriphenylphosphorane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=C)C1=CC=CC=C1 XYDYWTJEGDZLTH-UHFFFAOYSA-N 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- PEECTLLHENGOKU-UHFFFAOYSA-N n,n-dimethylpyridin-4-amine Chemical compound CN(C)C1=CC=NC=C1.CN(C)C1=CC=NC=C1 PEECTLLHENGOKU-UHFFFAOYSA-N 0.000 description 1
- XIOYBFAPRAMFJY-UHFFFAOYSA-N n-(6-methoxy-1,5-naphthyridin-4-yl)-3-piperidin-3-ylpropanamide Chemical compound C12=NC(OC)=CC=C2N=CC=C1NC(=O)CCC1CCCNC1 XIOYBFAPRAMFJY-UHFFFAOYSA-N 0.000 description 1
- YBSZEWLCECBDIP-UHFFFAOYSA-N n-[bis(dimethylamino)phosphoryl]-n-methylmethanamine Chemical compound CN(C)P(=O)(N(C)C)N(C)C.CN(C)P(=O)(N(C)C)N(C)C YBSZEWLCECBDIP-UHFFFAOYSA-N 0.000 description 1
- ONDXXAPHPJPFKQ-UHFFFAOYSA-N n-[bis(dimethylamino)phosphoryl]-n-methylmethanamine;oxolane Chemical compound C1CCOC1.CN(C)P(=O)(N(C)C)N(C)C ONDXXAPHPJPFKQ-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- WOOWBQQQJXZGIE-UHFFFAOYSA-N n-ethyl-n-propan-2-ylpropan-2-amine Chemical compound CCN(C(C)C)C(C)C.CCN(C(C)C)C(C)C WOOWBQQQJXZGIE-UHFFFAOYSA-N 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- ZOCHHNOQQHDWHG-UHFFFAOYSA-N n-hexan-3-ol Natural products CCCC(O)CC ZOCHHNOQQHDWHG-UHFFFAOYSA-N 0.000 description 1
- 125000001298 n-hexoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 description 1
- SJYNFBVQFBRSIB-UHFFFAOYSA-N norbornadiene Chemical compound C1=CC2C=CC1C2 SJYNFBVQFBRSIB-UHFFFAOYSA-N 0.000 description 1
- 238000005935 nucleophilic addition reaction Methods 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- PWOSZMWKBDDSPV-UHFFFAOYSA-N o-quinazolin-4-ylhydroxylamine Chemical compound C1=CC=C2C(ON)=NC=NC2=C1 PWOSZMWKBDDSPV-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 239000012285 osmium tetroxide Substances 0.000 description 1
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 238000005949 ozonolysis reaction Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- HWYNYLXTVJYPOW-UHFFFAOYSA-N piperidine-1,3-dicarboxylic acid Chemical compound OC(=O)C1CCCN(C(O)=O)C1 HWYNYLXTVJYPOW-UHFFFAOYSA-N 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 229950000033 proxetil Drugs 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical class C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- SAAYZFAHJFPOHZ-UHFFFAOYSA-N quinoxalin-5-amine Chemical compound C1=CN=C2C(N)=CC=CC2=N1 SAAYZFAHJFPOHZ-UHFFFAOYSA-N 0.000 description 1
- 150000003252 quinoxalines Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000008261 resistance mechanism Effects 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- KXCAEQNNTZANTK-UHFFFAOYSA-N stannane Chemical compound [SnH4] KXCAEQNNTZANTK-UHFFFAOYSA-N 0.000 description 1
- 229910000080 stannane Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 125000005415 substituted alkoxy group Chemical group 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- VDGHTMGOSYOOFV-QWHCGFSZSA-N tert-butyl (2R,5S)-5-amino-2-(2-tert-butylsilyloxypropan-2-yl)piperidine-1-carboxylate Chemical compound C(C)(C)(C)OC(=O)N1[C@H](CC[C@@H](C1)N)C(O[SiH2]C(C)(C)C)(C)C VDGHTMGOSYOOFV-QWHCGFSZSA-N 0.000 description 1
- DIQOZPGKFVICKN-UHFFFAOYSA-N tert-butyl 3-(3-hydroxypropyl)piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCC(CCCO)C1 DIQOZPGKFVICKN-UHFFFAOYSA-N 0.000 description 1
- CVBPSEVGGVOTBG-OLZOCXBDSA-N tert-butyl N-[(3R,6S)-6-(2-tert-butylsilyloxypropan-2-yl)-3,6-dihydro-2H-pyran-3-yl]carbamate Chemical compound C(C)(C)(C)OC(N[C@H]1CO[C@@H](C=C1)C(O[SiH2]C(C)(C)C)(C)C)=O CVBPSEVGGVOTBG-OLZOCXBDSA-N 0.000 description 1
- MSRPSAVQAPHELW-HZPDHXFCSA-N tert-butyl n-[(3r,6r)-6-[2-(6-methoxy-1,5-naphthyridin-4-yl)ethyl]oxan-3-yl]carbamate Chemical compound C12=NC(OC)=CC=C2N=CC=C1CC[C@@H]1CC[C@@H](NC(=O)OC(C)(C)C)CO1 MSRPSAVQAPHELW-HZPDHXFCSA-N 0.000 description 1
- KACHEPKGJVBQTP-BDAKNGLRSA-N tert-butyl n-[(3r,6s)-6-(hydroxymethyl)-3,6-dihydro-2h-pyran-3-yl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@H]1CO[C@H](CO)C=C1 KACHEPKGJVBQTP-BDAKNGLRSA-N 0.000 description 1
- JIDWDTKCBYAIFJ-NHAHKUSKSA-N tert-butyl n-[(3r,6s)-6-[(1s,2s)-1,2-dihydroxy-2-(6-methoxy-1,5-naphthyridin-4-yl)ethyl]oxan-3-yl]carbamate Chemical compound C([C@H]1[C@@H](O)[C@@H](O)C2=CC=NC3=CC=C(N=C32)OC)C[C@@H](NC(=O)OC(C)(C)C)CO1 JIDWDTKCBYAIFJ-NHAHKUSKSA-N 0.000 description 1
- RWOHBVPVOZWRMG-BDAKNGLRSA-N tert-butyl n-[(3r,6s)-6-formyloxan-3-yl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@@H]1CC[C@@H](C=O)OC1 RWOHBVPVOZWRMG-BDAKNGLRSA-N 0.000 description 1
- CJTLODBTFGWIEZ-UHFFFAOYSA-N tert-butyl n-[[3-[(6-methoxy-1,5-naphthyridin-4-yl)carbamoyl]cyclohexyl]methyl]carbamate Chemical compound C12=NC(OC)=CC=C2N=CC=C1NC(=O)C1CCCC(CNC(=O)OC(C)(C)C)C1 CJTLODBTFGWIEZ-UHFFFAOYSA-N 0.000 description 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical compound C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 1
- XBXCNNQPRYLIDE-UHFFFAOYSA-N tert-butylcarbamic acid Chemical compound CC(C)(C)NC(O)=O XBXCNNQPRYLIDE-UHFFFAOYSA-N 0.000 description 1
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
- 150000003527 tetrahydropyrans Chemical class 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 125000003652 trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 1
- SIOVKLKJSOKLIF-HJWRWDBZSA-N trimethylsilyl (1z)-n-trimethylsilylethanimidate Chemical compound C[Si](C)(C)OC(/C)=N\[Si](C)(C)C SIOVKLKJSOKLIF-HJWRWDBZSA-N 0.000 description 1
- MHNHYTDAOYJUEZ-UHFFFAOYSA-N triphenylphosphane Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 MHNHYTDAOYJUEZ-UHFFFAOYSA-N 0.000 description 1
- ADZJWYULTMTLQZ-UHFFFAOYSA-N tritylphosphane;hydrobromide Chemical compound [Br-].C=1C=CC=CC=1C(C=1C=CC=CC=1)([PH3+])C1=CC=CC=C1 ADZJWYULTMTLQZ-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EPPCT/EP2004/010762 | 2004-09-24 | ||
EP2004010762 | 2004-09-24 | ||
EP2005007731 | 2005-07-15 | ||
EPPCT/EP2005/007731 | 2005-07-15 | ||
PCT/EP2005/010154 WO2006032466A2 (fr) | 2004-09-24 | 2005-09-20 | Nouveaux antibiotiques bicycliques |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2580621A1 true CA2580621A1 (fr) | 2006-03-30 |
Family
ID=36090370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002580621A Abandoned CA2580621A1 (fr) | 2004-09-24 | 2005-09-20 | Nouveaux antibiotiques bicycliques |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP4887297B2 (fr) |
AR (1) | AR050958A1 (fr) |
CA (1) | CA2580621A1 (fr) |
TW (1) | TW200615267A (fr) |
WO (1) | WO2006032466A2 (fr) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7709472B2 (en) | 2005-01-25 | 2010-05-04 | Glaxo Group Limited | Antibacterial agents |
US20090131444A1 (en) * | 2005-05-24 | 2009-05-21 | Astrazeneca Ab | Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity |
MY150958A (en) | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
EP1981881B1 (fr) | 2006-01-26 | 2011-12-07 | Actelion Pharmaceuticals Ltd. | Antibiotiques de type tétrahydropyranne |
JP5191053B2 (ja) | 2006-02-15 | 2013-04-24 | アクテリオン ファーマシューティカルズ リミテッド | エタノールまたは1,2−エタンジオールシクロヘキシル抗生物質誘導体 |
CA2643962A1 (fr) * | 2006-03-10 | 2007-09-20 | Actelion Pharmaceuticals Ltd | Composes antibiotiques |
JP2009532423A (ja) | 2006-04-06 | 2009-09-10 | グラクソ グループ リミテッド | 抗菌剤としてのピロロ−キノキサリノン誘導体 |
BRPI0712430A2 (pt) * | 2006-06-08 | 2012-07-03 | Speedel Experimenta Ag | piperidinas 2,5-di-substitìdas. |
EP1992628A1 (fr) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Dérivés et analogues de N-éthylquinolones et N-éthylazaquinolones |
TW200819457A (en) * | 2006-08-30 | 2008-05-01 | Actelion Pharmaceuticals Ltd | Spiro antibiotic derivatives |
CL2007003693A1 (es) * | 2006-12-22 | 2008-06-27 | Actelion Pharmaceuticals Ltd | Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas. |
CL2008001002A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
CL2008001003A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
US8389524B2 (en) | 2007-04-20 | 2013-03-05 | Glaxo Group Limited | Tricyclic nitrogen containing compounds as antibacterial agents |
US8193179B2 (en) | 2007-06-15 | 2012-06-05 | Actelion Pharmaceuticals, Ltd | 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
EP2005995A1 (fr) * | 2007-06-22 | 2008-12-24 | Glaxo Group Limited | Composés hétérocycliques pour le traitement de la tuberculose |
AU2008337096B2 (en) | 2007-12-18 | 2013-10-17 | Actelion Pharmaceuticals Ltd | 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
EP2080761A1 (fr) | 2008-01-18 | 2009-07-22 | Glaxo Group Limited | Composés |
KR101590202B1 (ko) | 2008-02-20 | 2016-01-29 | 액테리온 파마슈티칼 리미티드 | 아자트리사이클 항생 화합물 |
WO2009128019A1 (fr) | 2008-04-15 | 2009-10-22 | Actelion Pharmaceuticals Ltd | Antibiotiques tricycliques |
AU2009254738B2 (en) | 2008-06-03 | 2014-05-08 | Idorsia Pharmaceuticals Ltd | [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials |
RU2011108008A (ru) | 2008-08-04 | 2012-09-10 | Актелион Фармасьютиклз Лтд (Ch) | Производные трициклического алкиламинометилоксазолидинона |
AR073774A1 (es) | 2008-10-07 | 2010-12-01 | Actelion Pharmaceuticals Ltd | Compuestos antibioticos oxazolidinona triciclicos |
US20110275661A1 (en) | 2008-10-17 | 2011-11-10 | Glaxo Group Limited | Tricyclic nitrogen compounds used as antibacterials |
KR101322496B1 (ko) | 2008-11-17 | 2013-10-29 | 에프. 호프만-라 로슈 아게 | 나프틸아세트산 |
NZ593891A (en) | 2008-12-12 | 2013-05-31 | Actelion Pharmaceuticals Ltd | 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives |
US8318940B2 (en) | 2009-01-15 | 2012-11-27 | Glaxo Group Limited | Naphthyridin-2 (1 H)-one compounds useful as antibacterials |
CA2750047A1 (fr) | 2009-01-21 | 2010-07-29 | Basilea Pharmaceutica Ag | Nouveaux antibiotiques bicycliques |
AR076222A1 (es) | 2009-04-09 | 2011-05-26 | Actelion Pharmaceuticals Ltd | Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen |
BR112013007566A2 (pt) | 2010-09-28 | 2016-08-02 | Panacea Biotec Ltd | novos compostos bicíclicos |
SI2684880T1 (en) | 2011-03-10 | 2018-08-31 | Daiichi Sankyo Company, Limited | DERIVAT DISPIROPYROLIDINE |
WO2012125661A1 (fr) * | 2011-03-17 | 2012-09-20 | Merck Sharp & Dohme Corp. | Dérivés de 3-azabicyclo[3.1.0]hexane substitués utiles en tant qu'antagonistes de ccr2 |
CA2780403C (fr) * | 2011-06-17 | 2020-04-21 | Forest Laboratories Holdings Ltd. | Procedes de preparation de composes heterocycliques, y compris le trans-7-oxo-6-(sulfoxy)-1,6-diazabicyclo¬3,2,1|octane-2-carboxamide et ses sels |
AU2012275499A1 (en) * | 2011-06-27 | 2013-12-19 | Kyorin Pharmaceutical Co., Ltd. | Bridged bicyclic compounds for the treatment of bacterial infections |
US8470884B2 (en) | 2011-11-09 | 2013-06-25 | Hoffmann-La Roche Inc. | Alkenyl naphthylacetic acids |
EP2785721A1 (fr) | 2011-11-30 | 2014-10-08 | Actelion Pharmaceuticals Ltd. | Antibiotiques d'octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one 3,7-disubstituée |
PE20170501A1 (es) | 2014-08-22 | 2017-04-27 | Glaxosmithkline Ip Dev Ltd | Un procedimiento que comprende compuestos que administran a un sujeto infectado con neisseria gonorrhoeae |
UY36851A (es) | 2015-08-16 | 2017-03-31 | Glaxosmithkline Ip Dev Ltd | Compuestos para uso en aplicaciones antibacterianas |
SI3676297T1 (sl) * | 2017-09-01 | 2023-12-29 | Denali Therapeutics Inc. | Spojine, sestavki in postopki |
EP3682881A4 (fr) | 2017-09-14 | 2021-08-11 | Daiichi Sankyo Company, Limited | Composé à structure cyclique |
CN109082280B (zh) * | 2018-11-05 | 2020-07-28 | 宁夏中星显示材料有限公司 | 一种液晶材料的制备方法 |
MA54959A (fr) | 2019-02-13 | 2021-12-22 | Denali Therapeutics Inc | Composés, compositions et procédés |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004089942A2 (fr) * | 2001-10-02 | 2004-10-21 | Acadia Pharmaceuticals Inc. | Derives de benzimidazolidinone utilises en tant qu'agents muscariniques |
EP2181996A1 (fr) * | 2002-01-29 | 2010-05-05 | Glaxo Group Limited | Derivées d'aminopieridines |
AR040335A1 (es) * | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto |
TW200409637A (en) * | 2002-06-26 | 2004-06-16 | Glaxo Group Ltd | Compounds |
DE50312598D1 (de) * | 2002-10-10 | 2010-05-20 | Morphochem Ag Komb Chemie | Neue verbindungen mit antibakterieller aktivität |
DE10256405A1 (de) * | 2002-12-02 | 2004-06-17 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen, die Topoisomerase IV inhibieren |
DE10316081A1 (de) * | 2003-04-08 | 2004-10-21 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
JP2008507543A (ja) * | 2004-07-22 | 2008-03-13 | グラクソ グループ リミテッド | 抗細菌剤 |
DE102004041163A1 (de) * | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
-
2005
- 2005-09-20 CA CA002580621A patent/CA2580621A1/fr not_active Abandoned
- 2005-09-20 JP JP2007532823A patent/JP4887297B2/ja not_active Expired - Fee Related
- 2005-09-20 WO PCT/EP2005/010154 patent/WO2006032466A2/fr active Application Filing
- 2005-09-21 TW TW094132686A patent/TW200615267A/zh unknown
- 2005-09-26 AR ARP050104029A patent/AR050958A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR050958A1 (es) | 2006-12-06 |
WO2006032466A3 (fr) | 2006-12-14 |
JP2008514563A (ja) | 2008-05-08 |
WO2006032466A2 (fr) | 2006-03-30 |
TW200615267A (en) | 2006-05-16 |
JP4887297B2 (ja) | 2012-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2580621A1 (fr) | Nouveaux antibiotiques bicycliques | |
CA2876879C (fr) | Antibiotiques a base d'oxazolidinone | |
JP4522262B2 (ja) | 化合物 | |
TWI415853B (zh) | 三環唑啶酮抗生素化合物 | |
JP2005504747A (ja) | 薬物 | |
EP2167494B1 (fr) | Dérivés de 3-amino-6-(1-amino-éthyl)-tétrahydropyrane | |
EP2066678B1 (fr) | Dérivés spiraniques antibiotiques | |
US20070173532A1 (en) | New Piperidine Antibiotics | |
US9079922B2 (en) | 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives | |
KR20040010654A (ko) | 항균제용 질소-함유 비시클릭 헤테로고리 화합물 | |
EP1981881A1 (fr) | Antibiotiques de type tétrahydropyranne | |
CA2643962A1 (fr) | Composes antibiotiques | |
EP1799676A2 (fr) | Nouveaux antibiotiques bicycliques | |
EP1799674A1 (fr) | Nouveaux antibiotiques de piperidine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |
Effective date: 20130827 |